{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:22:56Z","timestamp":1787008976271,"version":"build-2736575974"},"reference-count":740,"publisher":"Oxford University Press (OUP)","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJNPPY"],"DOI":"10.1093\/ijnp\/pyw100","type":"journal-article","created":{"date-parts":[[2016,11,4]],"date-time":"2016-11-04T00:05:35Z","timestamp":1478217935000},"page":"pyw100","source":"Crossref","is-referenced-by-count":28,"title":["The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise Algorithm"],"prefix":"10.1093","author":[{"given":"Konstantinos N.","family":"Fountoulakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshmi","family":"Yatham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz","family":"Grunze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Vieta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Blier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siegfried","family":"Kasper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans Jurgen","family":"Moeller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,11,5]]},"reference":[{"key":"2016122218201361000_pyw100v2.1","first-page":"1447","article-title":"Expert consensus guidelines are released for the treatment of bipolar disorder. Consensus Development Conferences","volume":"55","year":"1997","journal-title":"Am Fam Physician"},{"key":"2016122218201361000_pyw100v2.2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v69n1014"},{"key":"2016122218201361000_pyw100v2.3","unstructured":"(2009) NCT00329108 study results. In."},{"key":"2016122218201361000_pyw100v2.4","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-199701000-00032"},{"key":"2016122218201361000_pyw100v2.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2012.05.003"},{"key":"2016122218201361000_pyw100v2.6","doi-asserted-by":"publisher","DOI":"10.1097\/YCT.0b013e31824f8296"},{"key":"2016122218201361000_pyw100v2.7","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1600-0447.1982.tb00921.x","article-title":"Comparison between zimelidine and desipramine in endogenous depression. A cross-over study","volume":"66","author":"Aberg-Wistedt","year":"1982","journal-title":"Acta Psychiatr Scand"},{"key":"2016122218201361000_pyw100v2.8","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0b013e3280c28410"},{"key":"2016122218201361000_pyw100v2.9","doi-asserted-by":"publisher","DOI":"10.1159\/000088445"},{"key":"2016122218201361000_pyw100v2.10","unstructured":"Allen MH Currier GW Hughes DH Reyes-Harde M Docherty JP (2001) The Expert Consensus Guideline Series. Treatment of behavioral emergencies. Postgrad Med:1\u201388; quiz 89\u201390."},{"key":"2016122218201361000_pyw100v2.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2004.08.002"},{"key":"2016122218201361000_pyw100v2.12","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.163.2.313"},{"key":"2016122218201361000_pyw100v2.13","doi-asserted-by":"crossref","first-page":"450","DOI":"10.4088\/JCP.08m04191","article-title":"Impact of antidepressant continuation after acute positive or partial treatment response for bipolar depression: a blinded, randomized study","volume":"70","author":"Altshuler","year":"2009","journal-title":"J Clin Psychiatry"},{"key":"2016122218201361000_pyw100v2.14","first-page":"1289","article-title":"Lamotrigine: when and where does it act in affective disorders? A systematic review","volume":"10","author":"Amann","year":"2010","journal-title":"J Psychopharmacol"},{"key":"2016122218201361000_pyw100v2.15","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jad.2010.08.015","article-title":"Double-blind, randomized, placebo-controlled 6-week study on the efficacy and safety of the tamoxifen adjunctive to lithium in acute bipolar mania","volume":"129","author":"Amrollahi","year":"2010","journal-title":"J Affect Disord"},{"key":"2016122218201361000_pyw100v2.16","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(99)00149-4"},{"key":"2016122218201361000_pyw100v2.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2005.02.018"},{"key":"2016122218201361000_pyw100v2.18","doi-asserted-by":"publisher","DOI":"10.1097\/01.yic.0000171519.64080.c9"},{"key":"2016122218201361000_pyw100v2.19","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2009.09020284"},{"key":"2016122218201361000_pyw100v2.20","doi-asserted-by":"publisher","DOI":"10.1046\/j.1399-5618.2003.00083.x"},{"key":"2016122218201361000_pyw100v2.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2015.05.070"},{"key":"2016122218201361000_pyw100v2.22","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199812000-00003"},{"key":"2016122218201361000_pyw100v2.23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2011.00971.x"},{"key":"2016122218201361000_pyw100v2.24","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181ea157e"},{"key":"2016122218201361000_pyw100v2.25","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(01)00377-9"},{"key":"2016122218201361000_pyw100v2.26","doi-asserted-by":"publisher","DOI":"10.1159\/000284227"},{"key":"2016122218201361000_pyw100v2.27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1176\/ajp.151.12.1","article-title":"Practice guideline for the treatment of patients with bipolar disorder","volume":"151","year":"1994","journal-title":"Am J Psychiatry"},{"key":"2016122218201361000_pyw100v2.28","first-page":"1605","article-title":"American Psychiatric Association releases treatment guideline for bipolar disease","volume":"51","year":"1995","journal-title":"Am Fam Physician"},{"key":"2016122218201361000_pyw100v2.29","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.159.1.1"},{"key":"2016122218201361000_pyw100v2.30","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/bdi.12324","article-title":"Celecoxib adjunctive therapy for acute bipolar mania: a randomized, double-blind, placebo-controlled trial","volume":"17","author":"Arabzadeh","year":"2015","journal-title":"Bipolar Disord"},{"key":"2016122218201361000_pyw100v2.31","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0909801"},{"key":"2016122218201361000_pyw100v2.32","doi-asserted-by":"publisher","DOI":"10.1186\/1744-859X-4-5"},{"key":"2016122218201361000_pyw100v2.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2012.07.013"},{"key":"2016122218201361000_pyw100v2.34","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(70)92870-9"},{"key":"2016122218201361000_pyw100v2.35","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1600-0447.2009.01493.x","article-title":"Electroconvulsive therapy is equally effective in unipolar and bipolar depression","volume":"121","author":"Bailine","year":"2010","journal-title":"Acta Psychiatr Scand"},{"key":"2016122218201361000_pyw100v2.36","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1034\/j.1399-5618.2002.40103.x","article-title":"The impact of response to previous mood stabilizer therapy on response to olanzapine versus placebo for acute mania","volume":"4","author":"Baker","year":"2002","journal-title":"Bipolar Disord"},{"key":"2016122218201361000_pyw100v2.37","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200304000-00005"},{"key":"2016122218201361000_pyw100v2.38","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.185.6.472"},{"key":"2016122218201361000_pyw100v2.39","first-page":"44","article-title":"Lithium treatment and suicide risk in major affective disorders: update and new findings","volume":"64","author":"Baldessarini","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"2016122218201361000_pyw100v2.40","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000085410.08426.9a"},{"key":"2016122218201361000_pyw100v2.41","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v67n0215"},{"key":"2016122218201361000_pyw100v2.42","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.137.7.782"},{"key":"2016122218201361000_pyw100v2.43","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jad.2014.11.038","article-title":"A web-based preventive intervention program for bipolar disorder: outcome of a 12-months randomized controlled trial","volume":"174","author":"Barnes","year":"2015","journal-title":"J Affect Disord"},{"key":"2016122218201361000_pyw100v2.44","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1975.01760270039003"},{"key":"2016122218201361000_pyw100v2.45","doi-asserted-by":"publisher","DOI":"10.1093\/hrp\/7.4.230"},{"key":"2016122218201361000_pyw100v2.46","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199904000-00012"},{"key":"2016122218201361000_pyw100v2.47","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/mp.2014.186","article-title":"Levothyroxine effects on depressive symptoms and limbic glucose metabolism in bipolar disorder: a randomized, placebo-controlled positron emission tomography study","volume":"21","author":"Bauer","year":"2016","journal-title":"Molecular psychiatry"},{"key":"2016122218201361000_pyw100v2.48","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1990.01810170035006"},{"key":"2016122218201361000_pyw100v2.49","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1990.01810170027005"},{"key":"2016122218201361000_pyw100v2.50","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v60n0104"},{"key":"2016122218201361000_pyw100v2.51","doi-asserted-by":"crossref","unstructured":"Baumhackl U Biziere K Fischbach R Geretsegger C Hebenstreit G Radmayr E Stabl M (1989) Efficacy and tolerability of moclobemide compared with imipramine in depressive disorder (DSM-III): an Austrian double-blind, multicentre study. The British journal of psychiatry Supplement:78\u201383.","DOI":"10.1192\/S0007125000297535"},{"key":"2016122218201361000_pyw100v2.52","first-page":"38","article-title":"The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid substance use disorders","volume":"24","author":"Beaulieu","year":"2012","journal-title":"Ann Clin Psychiatry"},{"key":"2016122218201361000_pyw100v2.53","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145701002565"},{"key":"2016122218201361000_pyw100v2.54","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200216010-00004"},{"key":"2016122218201361000_pyw100v2.55","doi-asserted-by":"publisher","DOI":"10.1159\/000093947"},{"key":"2016122218201361000_pyw100v2.56","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.2009.01368.x"},{"key":"2016122218201361000_pyw100v2.57","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.08m04772gre"},{"key":"2016122218201361000_pyw100v2.58","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199911000-00003"},{"key":"2016122218201361000_pyw100v2.59","doi-asserted-by":"crossref","first-page":"728","DOI":"10.4088\/JCP.13m08827","article-title":"Effects of asenapine in bipolar I patients meeting proxy criteria for moderate-to-severe mixed major depressive episodes: a post hoc analysis","volume":"76","author":"Berk","year":"2015","journal-title":"J Clin Psychiatry"},{"key":"2016122218201361000_pyw100v2.60","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2008.04.022"},{"key":"2016122218201361000_pyw100v2.61","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-10-91"},{"key":"2016122218201361000_pyw100v2.62","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1601-5215.2009.00397.x","article-title":"Effects of N-acetylcysteine on substance use in bipolar disorder: A randomised placebo-controlled clinical trial","volume":"21","author":"Bernardo","year":"2009","journal-title":"Acta Neuropsychiatr"},{"key":"2016122218201361000_pyw100v2.63","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1399-5618.2010.00828.x","article-title":"Valnoctamide as a valproate substitute with low teratogenic potential in mania: a double-blind, controlled, add-on clinical trial","volume":"12","author":"Bersudsky","year":"2010","journal-title":"Bipolar Disord"},{"key":"2016122218201361000_pyw100v2.64","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-198611030-00001"},{"key":"2016122218201361000_pyw100v2.65","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2012.01.047"},{"key":"2016122218201361000_pyw100v2.66","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2010.06.030"},{"key":"2016122218201361000_pyw100v2.67","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2010.09.011"},{"key":"2016122218201361000_pyw100v2.68","doi-asserted-by":"publisher","DOI":"10.1177\/0269881108093885"},{"key":"2016122218201361000_pyw100v2.69","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1002\/j.1875-9114.1998.tb03148.x","article-title":"Antiepileptics and blood dyscrasias: A cohort study","volume":"18","author":"Blackburn","year":"1998","journal-title":"Pharmacotherapy"},{"key":"2016122218201361000_pyw100v2.70","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1586\/ern.10.143","article-title":"Risperidone long-acting injecTable (Risperdal Consta(R)) for maintenance treatment in patients with bipolar disorder","volume":"10","author":"Bobo","year":"2010","journal-title":"Expert Rev Neurother"},{"key":"2016122218201361000_pyw100v2.71","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1993.tb03487.x"},{"key":"2016122218201361000_pyw100v2.72","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2009.11.008"},{"key":"2016122218201361000_pyw100v2.73","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v69n1009"},{"key":"2016122218201361000_pyw100v2.74","first-page":"23","article-title":"The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid attention-deficit\/hyperactivity disorder","volume":"24","author":"Bond","year":"2012","journal-title":"Ann Clin Psychiatry"},{"key":"2016122218201361000_pyw100v2.75","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.12287"},{"key":"2016122218201361000_pyw100v2.76","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1399-5618.2007.00469.x","article-title":"The effect of previous psychotic mood episodes on cognitive impairment in euthymic bipolar patients","volume":"9","author":"Bora","year":"2007","journal-title":"Bipolar Disord"},{"key":"2016122218201361000_pyw100v2.77","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(00)00172-5"},{"key":"2016122218201361000_pyw100v2.78","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0165-0327(02)00265-3","article-title":"Mixed depressive features predict maniform switch during treatment of depression in bipolar I disorder","volume":"78","author":"Bottlender","year":"2004","journal-title":"J Affect Disord"},{"key":"2016122218201361000_pyw100v2.79","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40345-014-0014-9","article-title":"Lithium as add-on to quetiapine XR in adult patients with acute mania: a 6-week, multicenter, double-blind, randomized, placebo-controlled study","volume":"2","author":"Bourin","year":"2014","journal-title":"International journal of bipolar disorders"},{"key":"2016122218201361000_pyw100v2.80","first-page":"12","article-title":"Atypical antipsychotic augmentation of mood stabilizer therapy in bipolar disorder","volume":"66","author":"Bowden","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"2016122218201361000_pyw100v2.81","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.09m05482yel"},{"key":"2016122218201361000_pyw100v2.82","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300788"},{"key":"2016122218201361000_pyw100v2.83","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.2012.01890.x"},{"key":"2016122218201361000_pyw100v2.84","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v66n0116"},{"key":"2016122218201361000_pyw100v2.85","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v67n1003"},{"key":"2016122218201361000_pyw100v2.86","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1994.03510360044034"},{"key":"2016122218201361000_pyw100v2.87","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.60.4.392"},{"key":"2016122218201361000_pyw100v2.88","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.57.5.481"},{"key":"2016122218201361000_pyw100v2.89","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-198907000-00005"},{"key":"2016122218201361000_pyw100v2.90","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145708009735"},{"key":"2016122218201361000_pyw100v2.91","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v67n0703"},{"key":"2016122218201361000_pyw100v2.92","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v69n0502"},{"key":"2016122218201361000_pyw100v2.93","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1038\/npp.2014.138","article-title":"A randomized, double-blind, placebo-controlled trial of pregnenolone for bipolar depression","volume":"39","author":"Brown","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"2016122218201361000_pyw100v2.94","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1176\/appi.ajp.2015.14070857","article-title":"A Randomized, Double-Blind, Placebo-Controlled Trial of Citicoline for Cocaine Dependence in Bipolar I Disorder","volume":"172","author":"Brown","year":"2015","journal-title":"Am J Psychiatry"},{"key":"2016122218201361000_pyw100v2.95","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2006.06.014"},{"key":"2016122218201361000_pyw100v2.96","doi-asserted-by":"crossref","first-page":"103","DOI":"10.4088\/JCP.11m07299","article-title":"Placebo-controlled adjunctive trial of pramipexole in patients with bipolar disorder: targeting cognitive dysfunction","volume":"73","author":"Burdick","year":"2011","journal-title":"J Clin Psychiatry"},{"key":"2016122218201361000_pyw100v2.97","doi-asserted-by":"crossref","first-page":"103","DOI":"10.4088\/JCP.11m07299","article-title":"Placebo-controlled adjunctive trial of pramipexole in patients with bipolar disorder: targeting cognitive dysfunction","volume":"73","author":"Burdick","year":"2012","journal-title":"J Clin Psychiatry"},{"key":"2016122218201361000_pyw100v2.98","doi-asserted-by":"crossref","unstructured":"Burgess S Geddes J Hawton K Townsend E Jamison K Goodwin G (2001) Lithium for maintenance treatment of mood disorders. Cochrane Database Syst Rev:CD003013.","DOI":"10.1002\/14651858.CD003013"},{"key":"2016122218201361000_pyw100v2.99","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-977X(03)00079-8"},{"key":"2016122218201361000_pyw100v2.100","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.4088\/JCP.13m08951","article-title":"Efficacy and safety of adjunctive armodafinil in adults with major depressive episodes associated with bipolar I disorder: a randomized, double-blind, placebo-controlled, multicenter trial","volume":"75","author":"Calabrese","year":"2014","journal-title":"J Clin Psychiatry"},{"key":"2016122218201361000_pyw100v2.101","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v60n0203"},{"key":"2016122218201361000_pyw100v2.102","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.09m05900gry"},{"key":"2016122218201361000_pyw100v2.103","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.162.11.2152"},{"key":"2016122218201361000_pyw100v2.104","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2006.02.034"},{"key":"2016122218201361000_pyw100v2.105","doi-asserted-by":"crossref","first-page":"284","DOI":"10.4088\/JCP.14m09081","article-title":"Efficacy and safety of low- and high-dose cariprazine in acute and mixed mania associated with bipolar I disorder: a double-blind, placebo-controlled study","volume":"76","author":"Calabrese","year":"2015","journal-title":"J Clin Psychiatry"},{"key":"2016122218201361000_pyw100v2.106","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.162.7.1351"},{"key":"2016122218201361000_pyw100v2.107","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v61n1106"},{"key":"2016122218201361000_pyw100v2.108","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v64n0906"},{"key":"2016122218201361000_pyw100v2.109","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1097\/NMD.0000000000000369","article-title":"Biological Rhythm and Bipolar Disorder: Twelve-Month Follow-Up of a Randomized Clinical Trial","volume":"203","author":"Cardoso Tde","year":"2015","journal-title":"The Journal of nervous and mental disease"},{"key":"2016122218201361000_pyw100v2.110","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1399-5618.2011.00974.x","article-title":"Aripiprazole in combination with lamotrigine for the long-term treatment of patients with bipolar I disorder (manic or mixed): a randomized, multicenter, double-blind study (CN138-392)","volume":"14","author":"Carlson","year":"2012","journal-title":"Bipolar Disord"},{"key":"2016122218201361000_pyw100v2.111","first-page":"409","article-title":"Asenapine effects on individual Young Mania Rating Scale items in bipolar disorder patients with acute manic or mixed episodes: a pooled analysis","volume":"9","author":"Cazorla","year":"2013","journal-title":"Neuropsychiatric disease and treatment"},{"key":"2016122218201361000_pyw100v2.112","doi-asserted-by":"publisher","DOI":"10.1186\/1747-597X-2-29"},{"key":"2016122218201361000_pyw100v2.113","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.psyneuen.2016.08.005","article-title":"Polycystic ovary syndrome and psychiatric disorders: Co-morbidity and heritability in a nationwide Swedish cohort","volume":"73","author":"Cesta","year":"2016","journal-title":"Psychoneuroendocrinology"},{"key":"2016122218201361000_pyw100v2.114","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.clinthera.2015.11.013","article-title":"Lurasidone Dose Response in Bipolar Depression: A Population Dose-response Analysis","volume":"38","author":"Chapel","year":"2016","journal-title":"Clin Ther"},{"key":"2016122218201361000_pyw100v2.115","doi-asserted-by":"crossref","first-page":"839","DOI":"10.2147\/NDT.S40503","article-title":"A randomized, 4-week double-blind placebo control study on the efficacy of donepezil augmentation of lithium for treatment of acute mania","volume":"9","author":"Chen","year":"2013","journal-title":"Neuropsychiatric disease and treatment"},{"key":"2016122218201361000_pyw100v2.116","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-5618.2003.02237.x"},{"key":"2016122218201361000_pyw100v2.117","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v66n1219b"},{"key":"2016122218201361000_pyw100v2.118","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199912000-00003"},{"key":"2016122218201361000_pyw100v2.119","first-page":"S114","article-title":"A double-blind randomized clinical trial of rapid tranquilization with I.M. clonazepam and I.M. haloperidol in agitated psychotic patients with manic symptoms","volume":"38","author":"Chouinard","year":"1993","journal-title":"Can J Psychiatry"},{"key":"2016122218201361000_pyw100v2.120","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1982.tb00852.x"},{"key":"2016122218201361000_pyw100v2.121","first-page":"CD004362","article-title":"Haloperidol alone or in combination for acute mania","volume":"3","author":"Cipriani","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"2016122218201361000_pyw100v2.122","doi-asserted-by":"publisher","DOI":"10.1177\/0269881109106900"},{"key":"2016122218201361000_pyw100v2.123","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f3646"},{"key":"2016122218201361000_pyw100v2.124","doi-asserted-by":"crossref","unstructured":"Cipriani A Smith K Burgess S Carney S Goodwin G Geddes J (2006b) Lithium versus antidepressants in the long-term treatment of unipolar affective disorder. Cochrane Database Syst Rev:CD003492.","DOI":"10.1002\/14651858.CD003492.pub2"},{"key":"2016122218201361000_pyw100v2.125","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60873-8"},{"key":"2016122218201361000_pyw100v2.126","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1586\/ern.10.66","article-title":"Ziprasidone HCl capsules for the adjunctive maintenance treatment of bipolar disorder in adults","volume":"10","author":"Citrome","year":"2010","journal-title":"Expert Rev Neurother"},{"key":"2016122218201361000_pyw100v2.127","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1742-1241.2011.02890.x","article-title":"Inhaled loxapine for agitation revisited: focus on effect sizes from 2 Phase III randomised controlled trials in persons with schizophrenia or bipolar disorder","volume":"66","author":"Citrome","year":"2012","journal-title":"Int J Clin Pract"},{"key":"2016122218201361000_pyw100v2.128","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2013.10.040"},{"key":"2016122218201361000_pyw100v2.129","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/YIC.0000000000000106","article-title":"Effect of aripiprazole lauroxil on agitation and hostility in patients with schizophrenia","volume":"31","author":"Citrome","year":"2016","journal-title":"Int Clin Psychopharmacol"},{"key":"2016122218201361000_pyw100v2.130","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-198910000-00006"},{"key":"2016122218201361000_pyw100v2.131","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/01.pra.0000348369.19172.ba","article-title":"Aripiprazole prescribing patterns and side effects in elderly psychiatric inpatients","volume":"15","author":"Coley","year":"2009","journal-title":"Journal of psychiatric practice"},{"key":"2016122218201361000_pyw100v2.132","first-page":"260","article-title":"Group psychoeducation for stabilised bipolar disorders: 5-year outcome of a randomised clinical trial","volume":"194","author":"Colom","year":"2009","journal-title":"BrJPsychiatry"},{"key":"2016122218201361000_pyw100v2.133","first-page":"402","article-title":"A randomized trial on the efficacy of group psychoeducation in the prophylaxis of recurrences in bipolar patients whose disease is in remission","volume":"60","author":"Colom","year":"2003","journal-title":"ArchGenPsychiatry"},{"key":"2016122218201361000_pyw100v2.134","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1601-5215.2010.00450.x","article-title":"Has number of previous episodes any effect on respones to group psychoeducation in bipolar patients?","volume":"22","author":"Colom","year":"2010","journal-title":"Acta Neuropsychiatrica"},{"key":"2016122218201361000_pyw100v2.135","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1982.04290050057011"},{"key":"2016122218201361000_pyw100v2.136","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1981.tb00797.x"},{"key":"2016122218201361000_pyw100v2.137","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0b013e3280119dfb"},{"key":"2016122218201361000_pyw100v2.138","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1972.01750210042009"},{"key":"2016122218201361000_pyw100v2.139","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.13r08851"},{"key":"2016122218201361000_pyw100v2.140","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2010.00798.x"},{"key":"2016122218201361000_pyw100v2.141","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1590\/S1516-44462011000200009","article-title":"The effectiveness of cognitive behavioral group therapy in treating bipolar disorder: a randomized controlled study","volume":"33","author":"Costa","year":"2011","journal-title":"Revista brasileira de psiquiatria"},{"key":"2016122218201361000_pyw100v2.142","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1983.01790040068010"},{"key":"2016122218201361000_pyw100v2.143","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1992.tb01453.x"},{"key":"2016122218201361000_pyw100v2.144","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145709990344"},{"key":"2016122218201361000_pyw100v2.145","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291700042616"},{"key":"2016122218201361000_pyw100v2.146","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.clinthera.2011.10.002","article-title":"Extended-release quetiapine as monotherapy for the treatment of adults with acute mania: a randomized, double-blind, 3-week trial","volume":"33","author":"Cutler","year":"2011","journal-title":"Clin Ther"},{"key":"2016122218201361000_pyw100v2.147","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2009.03.018"},{"key":"2016122218201361000_pyw100v2.148","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-5618.2001.030208.x"},{"key":"2016122218201361000_pyw100v2.149","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.166.3.378"},{"key":"2016122218201361000_pyw100v2.150","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.psychres.2012.01.015","article-title":"Controlled trial of safety and efficacy of bright light therapy vs negative air ions in patients with bipolar depression","volume":"196","author":"Dauphinais","year":"2012","journal-title":"Psychiatry Res"},{"key":"2016122218201361000_pyw100v2.151","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1999.tb10890.x"},{"key":"2016122218201361000_pyw100v2.152","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2004.09.009"},{"key":"2016122218201361000_pyw100v2.153","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/acps.12007","article-title":"Efficacy of psychoeducation on symptomatic and functional recovery in bipolar disorder","volume":"127","author":"de Barros","year":"2013","journal-title":"Acta PsychiatrScand"},{"key":"2016122218201361000_pyw100v2.154","doi-asserted-by":"publisher","DOI":"10.1177\/0269881111408461"},{"key":"2016122218201361000_pyw100v2.155","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/bdi.12105","article-title":"The effectiveness of restarted lithium treatment after discontinuation: reviewing the evidence for discontinuation-induced refractoriness","volume":"15","author":"de Vries","year":"2013","journal-title":"Bipolar Disord"},{"key":"2016122218201361000_pyw100v2.156","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1819.2012.02392.x"},{"key":"2016122218201361000_pyw100v2.157","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1399-5618.2008.00651.x","article-title":"Augmentative repetitive navigated transcranial magnetic stimulation (rTMS) in drug-resistant bipolar depression","volume":"11","author":"Dell\u2019Osso","year":"2009","journal-title":"Bipolar Disord"},{"key":"2016122218201361000_pyw100v2.158","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v58n1102"},{"key":"2016122218201361000_pyw100v2.159","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-000-0074-7"},{"key":"2016122218201361000_pyw100v2.160","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2014.10.053"},{"key":"2016122218201361000_pyw100v2.161","doi-asserted-by":"publisher","DOI":"10.1037\/1064-1297.15.6.569"},{"key":"2016122218201361000_pyw100v2.162","doi-asserted-by":"publisher","DOI":"10.1001\/archgenpsychiatry.2010.90"},{"key":"2016122218201361000_pyw100v2.163","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2012.00997.x"},{"key":"2016122218201361000_pyw100v2.164","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.135.5.552"},{"key":"2016122218201361000_pyw100v2.165","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1399-5618.2007.00491.x","article-title":"Onset of antidepressant effect of olanzapine and olanzapine\/fluoxetine combination in bipolar depression","volume":"9","author":"Dube","year":"2007","journal-title":"Bipolar Disord"},{"key":"2016122218201361000_pyw100v2.166","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1976.01770010073014"},{"key":"2016122218201361000_pyw100v2.167","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.12238"},{"key":"2016122218201361000_pyw100v2.168","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2015.15020164"},{"key":"2016122218201361000_pyw100v2.169","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1399-5618.2006.00243.x","article-title":"A double-blind, placebo-controlled trial of adjunctive donepezil in treatment-resistant mania","volume":"8","author":"Eden Evins","year":"2006","journal-title":"Bipolar Disord"},{"key":"2016122218201361000_pyw100v2.170","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1399-5618.2006.00303.x","article-title":"Inositol augmentation of lithium or valproate for bipolar depression","volume":"8","author":"Eden Evins","year":"2006","journal-title":"Bipolar Disord"},{"key":"2016122218201361000_pyw100v2.171","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jad.2011.11.043","article-title":"A 40-week double-blind aripiprazole versus lithium follow-up of a 12-week acute phase study (total 52 weeks) in bipolar I disorder","volume":"136","author":"El-Mallakh","year":"2012","journal-title":"J Affect Disord"},{"key":"2016122218201361000_pyw100v2.172","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2008.03.025"},{"key":"2016122218201361000_pyw100v2.173","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2015.04.054"},{"key":"2016122218201361000_pyw100v2.174","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2010.07.003"},{"key":"2016122218201361000_pyw100v2.175","doi-asserted-by":"publisher","DOI":"10.1016\/0924-977X(96)00029-6"},{"key":"2016122218201361000_pyw100v2.176","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.138.2.256"},{"key":"2016122218201361000_pyw100v2.177","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00343800","article-title":"Effect of sodium valproate on mania. The GABA-hypothesis of affective disorders","volume":"229","author":"Emrich","year":"1980","journal-title":"Archiv Psychiatrie Nervenkrankheiten"},{"key":"2016122218201361000_pyw100v2.178","doi-asserted-by":"publisher","DOI":"10.1097\/01.yic.0000224797.74771.be"},{"key":"2016122218201361000_pyw100v2.179","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/00004714-198806000-00011","article-title":"Lithium and memory: a long-term follow-up study","volume":"8","author":"Engelsmann","year":"1988","journal-title":"J Clin Psychopharmacol"},{"key":"2016122218201361000_pyw100v2.180","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1399-5618.2012.01001.x","article-title":"Allopurinol augmentation in the outpatient treatment of bipolar mania: a pilot study","volume":"14","author":"Fan","year":"2012","journal-title":"Bipolar Disord"},{"key":"2016122218201361000_pyw100v2.181","unstructured":"FDA (2008) statistical review and evaluation: antiepileptic drugs and suicidality. Available online http:\/\/www.fda.gov\/ohrms\/dockets\/ac\/08\/briefing\/2008-4372b1-01-FDA.pdf."},{"key":"2016122218201361000_pyw100v2.182","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.133.8.925"},{"key":"2016122218201361000_pyw100v2.183","doi-asserted-by":"publisher","DOI":"10.1097\/01.chi.0000155981.83865.ea"},{"key":"2016122218201361000_pyw100v2.184","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-014-3664-5"},{"key":"2016122218201361000_pyw100v2.185","doi-asserted-by":"crossref","unstructured":"Fountoulakis K (2015a) Treatment guidelines. In: Bipolar disorder: an evidence-based guide to manic depression ( Fountoulakis K , ed), pp 643\u2013658. Berlin Heidelberg: Springer-Verlag.","DOI":"10.1007\/978-3-642-37216-2_18"},{"key":"2016122218201361000_pyw100v2.186","doi-asserted-by":"crossref","unstructured":"Fountoulakis K (2015b) Biological therapies. In: Bipolar disorder: an evidence-based guide to manic depression ( Fountoulakis K , ed), pp 461\u2013625. Berlin Heidelberg: Springer-Verlag.","DOI":"10.1007\/978-3-642-37216-2_16"},{"key":"2016122218201361000_pyw100v2.187","doi-asserted-by":"crossref","unstructured":"Fountoulakis K (2015c) Psychosocial Treatment and interventions. In: Bipolar disorder: an evidence-based guide to manic depression ( Fountoulakis K , ed), pp 627\u2013642. Berlin Heidelberg: Springer-Verlag.","DOI":"10.1007\/978-3-642-37216-2_17"},{"key":"2016122218201361000_pyw100v2.188","doi-asserted-by":"crossref","unstructured":"Fountoulakis K (2015d) Classification and epidemiology. In: Bipolar disorder: an evidence-based guide to manic depression ( Fountoulakis K , ed), pp 341\u2013360. Berlin Heidelberg: Springer-Verlag.","DOI":"10.1007\/978-3-642-37216-2_11"},{"key":"2016122218201361000_pyw100v2.189","doi-asserted-by":"crossref","unstructured":"Fountoulakis K (2015e) Comorbidity. In: Bipolar disorder: an evidence-based guide to manic depression ( Fountoulakis K , ed), pp 225\u2013340. Berlin Heidelberg: Springer-Verlag.","DOI":"10.1007\/978-3-642-37216-2_10"},{"key":"2016122218201361000_pyw100v2.190","doi-asserted-by":"crossref","unstructured":"Fountoulakis K (2015f) Personality Disorders (narcissistic, antisocial, borderline). In: Bipolar disorder: an evidence-based guide to manic depression ( Fountoulakis K , ed), pp 197\u2013204. Sp Berlin Heidelberg: Springer-Verlag.","DOI":"10.1007\/978-3-642-37216-2_8"},{"key":"2016122218201361000_pyw100v2.191","doi-asserted-by":"crossref","unstructured":"Fountoulakis K (2015g) Alcohol and substance use in BD patients. In: Bipolar disorder: an evidence-based guide to manic depression ( Fountoulakis K , ed), pp 205\u2013223. Berlin Heidelberg: Springer-Verlag.","DOI":"10.1007\/978-3-642-37216-2_9"},{"key":"2016122218201361000_pyw100v2.192","doi-asserted-by":"publisher","DOI":"10.1017\/S1092852900013894"},{"key":"2016122218201361000_pyw100v2.193","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1755-5949.2011.00259.x","article-title":"Refractoriness in bipolar disorder: definitions and evidence-based treatment","volume":"18","author":"Fountoulakis","year":"2012","journal-title":"CNS Neurosci Ther"},{"key":"2016122218201361000_pyw100v2.194","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145708009231"},{"key":"2016122218201361000_pyw100v2.195","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2011.234"},{"key":"2016122218201361000_pyw100v2.196","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0140-6736(12)60391-2","article-title":"Comparative efficacy of anti-manic drugs in acute mania","volume":"379","author":"Fountoulakis","year":"2012","journal-title":"Lancet"},{"key":"2016122218201361000_pyw100v2.197","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2010.10.018"},{"key":"2016122218201361000_pyw100v2.198","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2011.04.043"},{"key":"2016122218201361000_pyw100v2.199","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresrev.2008.04.005"},{"key":"2016122218201361000_pyw100v2.200","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1744-859X-8-27","article-title":"Treatment of psychotic symptoms in bipolar disorder with aripiprazole monotherapy: a meta-analysis","volume":"8","author":"Fountoulakis","year":"2009","journal-title":"Ann Gen Psychiatry"},{"key":"2016122218201361000_pyw100v2.201","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2008.06.014"},{"key":"2016122218201361000_pyw100v2.202","doi-asserted-by":"publisher","DOI":"10.1186\/1744-859X-10-8"},{"key":"2016122218201361000_pyw100v2.203","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.12045"},{"key":"2016122218201361000_pyw100v2.204","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145711001817"},{"key":"2016122218201361000_pyw100v2.205","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2005.01.004"},{"key":"2016122218201361000_pyw100v2.206","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145707007821"},{"key":"2016122218201361000_pyw100v2.207","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2007.11.006"},{"key":"2016122218201361000_pyw100v2.208","doi-asserted-by":"publisher","DOI":"10.1177\/0269881112440514"},{"key":"2016122218201361000_pyw100v2.209","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00406-012-0323-x","article-title":"Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry","volume":"262","author":"Fountoulakis","year":"2012","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"2016122218201361000_pyw100v2.210","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3109\/13651501.2014.1000930","article-title":"Report of the WPA section of pharmacopsychiatry on the relationship of antiepileptic drugs with suicidality in epilepsy","volume":"19","author":"Fountoulakis","year":"2015","journal-title":"Int J Psychiatry Clin Pract"},{"key":"2016122218201361000_pyw100v2.211","first-page":"1","article-title":"The expert consensus guideline series: treatment of bipolar disorder","volume":"57","author":"Frances","year":"1996","journal-title":"J Clin Psychiatry"},{"key":"2016122218201361000_pyw100v2.212","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.188.1.46"},{"key":"2016122218201361000_pyw100v2.213","doi-asserted-by":"publisher","DOI":"10.1177\/0269881106067787"},{"key":"2016122218201361000_pyw100v2.214","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2005.04.056"},{"key":"2016122218201361000_pyw100v2.215","first-page":"1559","article-title":"The role of interpersonal and social rhythm therapy in improving occupational functioning in patients with bipolar I disorder","volume":"165","author":"Frank","year":"2008","journal-title":"AmJPsychiatry"},{"key":"2016122218201361000_pyw100v2.216","first-page":"996","article-title":"Two-year outcomes for interpersonal and social rhythm therapy in individuals with bipolar I disorder","volume":"62","author":"Frank","year":"2005","journal-title":"ArchGenPsychiatry"},{"key":"2016122218201361000_pyw100v2.217","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.149.1.108"},{"key":"2016122218201361000_pyw100v2.218","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.4088\/JCP.v67n1108","article-title":"Incidence and time course of subsyndromal symptoms in patients with bipolar I disorder: an evaluation of 2 placebo-controlled maintenance trials","volume":"67","author":"Frye","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"2016122218201361000_pyw100v2.219","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.10123co1c"},{"key":"2016122218201361000_pyw100v2.220","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200012000-00004"},{"key":"2016122218201361000_pyw100v2.221","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1600-0447.2008.01343.x","article-title":"Depressive relapse during lithium treatment associated with increased serum thyroid-stimulating hormone: results from two placebo-controlled bipolar I maintenance studies","volume":"120","author":"Frye","year":"2009","journal-title":"Acta Psychiatr Scand"},{"key":"2016122218201361000_pyw100v2.222","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2007.06060981"},{"key":"2016122218201361000_pyw100v2.223","first-page":"17","article-title":"A double-blind study of the prophylactic effect of lithium in manic-depressive disease","volume":"269","author":"Fyro","year":"1977","journal-title":"Acta Psychiatr Scand"},{"key":"2016122218201361000_pyw100v2.224","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.2015.1053457"},{"key":"2016122218201361000_pyw100v2.225","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v66n1106"},{"key":"2016122218201361000_pyw100v2.226","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/JCP.0b013e3182917f3f","article-title":"Risk for adverse events and discontinuation due to adverse events of ziprasidone monotherapy relative to placebo in the acute treatment of bipolar depression, mania, and schizophrenia","volume":"33","author":"Gao","year":"2013","journal-title":"J Clin Psychopharmacol"},{"key":"2016122218201361000_pyw100v2.227","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.09r05535gre"},{"key":"2016122218201361000_pyw100v2.228","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.4088\/JCP.13m08847","article-title":"Efficacy and safety of quetiapine-XR as monotherapy or adjunctive therapy to a mood stabilizer in acute bipolar depression with generalized anxiety disorder and other comorbidities: a randomized, placebo-controlled trial","volume":"75","author":"Gao","year":"2014","journal-title":"J Clin Psychiatry"},{"key":"2016122218201361000_pyw100v2.229","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0327(80)90029-4"},{"key":"2016122218201361000_pyw100v2.230","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.107.048504"},{"key":"2016122218201361000_pyw100v2.231","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.161.2.217"},{"key":"2016122218201361000_pyw100v2.232","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61828-6"},{"key":"2016122218201361000_pyw100v2.233","doi-asserted-by":"publisher","DOI":"10.1016\/0278-5846(92)90080-X"},{"key":"2016122218201361000_pyw100v2.234","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-199802000-00009"},{"key":"2016122218201361000_pyw100v2.235","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.2008.01257.x"},{"key":"2016122218201361000_pyw100v2.236","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e3181a497d7"},{"key":"2016122218201361000_pyw100v2.237","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v68n1203"},{"key":"2016122218201361000_pyw100v2.238","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.08m04909gre"},{"key":"2016122218201361000_pyw100v2.239","doi-asserted-by":"crossref","first-page":"730505","DOI":"10.1155\/2014\/730505","article-title":"Lovastatin as an adjuvant to lithium for treating manic phase of bipolar disorder: a 4-week, randomized, double-blind, placebo-controlled clinical trial","volume":"2014","author":"Ghanizadeh","year":"2014","journal-title":"Depression Res Treatment"},{"key":"2016122218201361000_pyw100v2.240","doi-asserted-by":"publisher","DOI":"10.1001\/archgenpsychiatry.2009.159"},{"key":"2016122218201361000_pyw100v2.241","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2007.07030454"},{"key":"2016122218201361000_pyw100v2.242","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.161.9.1537"},{"key":"2016122218201361000_pyw100v2.243","doi-asserted-by":"crossref","first-page":"345","DOI":"10.4088\/JCP.v59n0702","article-title":"Texas Medication Algorithm Project: definitions, rationale, and methods to develop medication algorithms","volume":"59","author":"Gilbert","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"2016122218201361000_pyw100v2.244","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.euroneuro.2012.05.017","article-title":"Faster onset of antimanic action with haloperidol compared with second-generation antipsychotics. A meta-analysis of randomized clinical trials in acute mania","volume":"23","author":"Goikolea","year":"2013","journal-title":"Eur Neuropsychopharmacol"},{"key":"2016122218201361000_pyw100v2.245","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jad.2012.07.038","article-title":"Lower rate of depressive switch following antimanic treatment with second-generation antipsychotics versus haloperidol","volume":"144","author":"Goikolea","year":"2013","journal-title":"J Affect Disord"},{"key":"2016122218201361000_pyw100v2.246","doi-asserted-by":"crossref","unstructured":"Goldberg J (2008) Adverse cognitive effects of psychotropic medications. In: Cognitive dysfunction in bipolar disorder: a guide for clinicians ( Goldberg J Burdick K , eds), pp 137\u2013158. Washington, DC: American Psychiatric Press.","DOI":"10.1176\/appi.books.9781615377756.lg07"},{"key":"2016122218201361000_pyw100v2.247","first-page":"12","article-title":"Treatment guidelines: current and future management of bipolar disorder","volume":"61","author":"Goldberg","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"2016122218201361000_pyw100v2.248","doi-asserted-by":"publisher","DOI":"10.1046\/j.1399-5618.2003.00067.x"},{"key":"2016122218201361000_pyw100v2.249","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2009.00716.x"},{"key":"2016122218201361000_pyw100v2.250","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200363190-00009"},{"key":"2016122218201361000_pyw100v2.251","first-page":"144","article-title":"A randomized controlled trial of cognitive behavioral group therapy for bipolar disorder","volume":"80","author":"Gomes","year":"2011","journal-title":"PsychotherPsychosom"},{"key":"2016122218201361000_pyw100v2.252","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1185\/03007995.2013.766591","article-title":"Consensus statement on the use of intramuscular aripiprazole for the rapid control of agitation in bipolar mania and schizophrenia","volume":"29","author":"Gonzalez","year":"2013","journal-title":"Curr Med Res Opin"},{"key":"2016122218201361000_pyw100v2.253","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.eurpsy.2012.11.002","article-title":"Psychoeducation and cognitive-behavioral therapy for patients with refractory bipolar disorder: a 5-year controlled clinical trial","volume":"29","author":"Gonzalez Isasi","year":"2014","journal-title":"Eur Psychiatry"},{"key":"2016122218201361000_pyw100v2.254","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1969.01740220102012"},{"key":"2016122218201361000_pyw100v2.255","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.129.1.44"},{"key":"2016122218201361000_pyw100v2.256","doi-asserted-by":"publisher","DOI":"10.1001\/jama.290.11.1467"},{"key":"2016122218201361000_pyw100v2.257","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.3109\/13651509709024750","article-title":"Treatment of bipolar depressive mood disorders: algorithms for pharmacotherapy","volume":"1","author":"Goodwin","year":"1997","journal-title":"Int J Psychiatry Clin Pract"},{"key":"2016122218201361000_pyw100v2.258","doi-asserted-by":"publisher","DOI":"10.1177\/0269881103017002003"},{"key":"2016122218201361000_pyw100v2.259","doi-asserted-by":"publisher","DOI":"10.1177\/0269881109102919"},{"key":"2016122218201361000_pyw100v2.260","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v65n0321"},{"key":"2016122218201361000_pyw100v2.261","unstructured":"Goodwin GM . (2016) Evidence-based guidelines for treating bipolar disorder: revised third edition recommendations from the British Association for Psychopharmacology. J Psychopharmacol."},{"key":"2016122218201361000_pyw100v2.262","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v66n0809"},{"key":"2016122218201361000_pyw100v2.263","doi-asserted-by":"crossref","unstructured":"Grande I Berk M Birmaher B Vieta E (2015) Bipolar disorder. Lancet.","DOI":"10.1016\/S0140-6736(15)00241-X"},{"key":"2016122218201361000_pyw100v2.264","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3956(70)90004-X"},{"key":"2016122218201361000_pyw100v2.265","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199914050-00002"},{"key":"2016122218201361000_pyw100v2.266","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199914050-00003"},{"key":"2016122218201361000_pyw100v2.267","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199812000-00007"},{"key":"2016122218201361000_pyw100v2.268","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(96)01427-9"},{"key":"2016122218201361000_pyw100v2.269","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(99)00041-5"},{"key":"2016122218201361000_pyw100v2.270","doi-asserted-by":"publisher","DOI":"10.1080\/15622970410029924"},{"key":"2016122218201361000_pyw100v2.271","doi-asserted-by":"publisher","DOI":"10.1080\/15622970902823202"},{"key":"2016122218201361000_pyw100v2.272","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2014.11.013"},{"key":"2016122218201361000_pyw100v2.273","doi-asserted-by":"publisher","DOI":"10.3109\/15622970209150612"},{"key":"2016122218201361000_pyw100v2.274","doi-asserted-by":"publisher","DOI":"10.1080\/15622970310029920"},{"key":"2016122218201361000_pyw100v2.275","doi-asserted-by":"publisher","DOI":"10.3109\/15622970903555881"},{"key":"2016122218201361000_pyw100v2.276","doi-asserted-by":"publisher","DOI":"10.3109\/15622975.2013.770551"},{"key":"2016122218201361000_pyw100v2.277","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1017\/S1092852900013912","article-title":"Switching, induction of rapid cycling, and increased suicidality with antidepressants in bipolar patients: fact or overinterpretation?","volume":"13","author":"Grunze","year":"2008","journal-title":"CNS Spectr"},{"key":"2016122218201361000_pyw100v2.278","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0006-3223(02)01573-1","article-title":"Thyroid hypofunction in patients with rapid-cycling bipolar disorder after lithium challenge","volume":"53","author":"Gyulai","year":"2003","journal-title":"Biol Psychiatry"},{"key":"2016122218201361000_pyw100v2.279","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300190"},{"key":"2016122218201361000_pyw100v2.280","first-page":"121","article-title":"Effectiveness and safety of adjunctive antidepressants in the treatment of bipolar depression: a review","volume":"45","author":"Harel","year":"2008","journal-title":"Isr J Psychiatry Relat Sci"},{"key":"2016122218201361000_pyw100v2.281","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v64n0206"},{"key":"2016122218201361000_pyw100v2.282","doi-asserted-by":"publisher","DOI":"10.1037\/a0038655"},{"key":"2016122218201361000_pyw100v2.283","doi-asserted-by":"publisher","DOI":"10.1159\/000068691"},{"key":"2016122218201361000_pyw100v2.284","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/j.1528-1167.2009.02012.x","article-title":"The FDA alert on suicidality and antiepileptic drugs: Fire or false alarm?","volume":"50","author":"Hesdorffer","year":"2009","journal-title":"Epilepsia"},{"key":"2016122218201361000_pyw100v2.285","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1097\/00005053-198210000-00007","article-title":"A double-blind study of tranylcypromine treatment of major anergic depression","volume":"170","author":"Himmelhoch","year":"1982","journal-title":"The Journal of nervous and mental disease"},{"key":"2016122218201361000_pyw100v2.286","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.148.7.910"},{"key":"2016122218201361000_pyw100v2.287","unstructured":"Hirschfeld R (2005) Guideline Watch for the Practice Guideline for the Treatment of Patients With Bipolar Disorder. In. Arlington, VA: American Psychiatric Association."},{"key":"2016122218201361000_pyw100v2.288","doi-asserted-by":"crossref","first-page":"815","DOI":"10.4088\/JCP.v60n1202","article-title":"Safety and tolerability of oral loading divalproex sodium in acutely manic bipolar patients","volume":"60","author":"Hirschfeld","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"2016122218201361000_pyw100v2.289","doi-asserted-by":"crossref","first-page":"426","DOI":"10.4088\/JCP.08m04960yel","article-title":"A randomized, placebo-controlled, multicenter study of divalproex sodium extended-release in the acute treatment of mania","volume":"71","author":"Hirschfeld","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"2016122218201361000_pyw100v2.290","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.161.6.1057"},{"key":"2016122218201361000_pyw100v2.291","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/j.1399-5618.2008.00628.x","article-title":"A comparison of cognitive functioning in medicated and unmedicated subjects with bipolar depression","volume":"10","author":"Holmes","year":"2008","journal-title":"Bipolar Disord"},{"key":"2016122218201361000_pyw100v2.292","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199905002-00003"},{"key":"2016122218201361000_pyw100v2.293","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0050020"},{"key":"2016122218201361000_pyw100v2.294","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.4088\/JCP.v67n0811","article-title":"Reduced suicidal ideation in bipolar I disorder mixed-episode patients in a placebo-controlled trial of olanzapine combined with lithium or divalproex","volume":"67","author":"Houston","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"2016122218201361000_pyw100v2.295","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.4088\/JCP.08m04895yel","article-title":"Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study","volume":"70","author":"Houston","year":"2009","journal-title":"J Clin Psychiatry"},{"key":"2016122218201361000_pyw100v2.296","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2010.05.016"},{"key":"2016122218201361000_pyw100v2.297","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(72)91222-6"},{"key":"2016122218201361000_pyw100v2.298","doi-asserted-by":"publisher","DOI":"10.1023\/A:1009066725103"},{"key":"2016122218201361000_pyw100v2.299","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/bdi.12273","article-title":"Randomized, controlled trial of Interpersonal and Social Rhythm Therapy for young people with bipolar disorder","volume":"17","author":"Inder","year":"2015","journal-title":"Bipolar Disord"},{"key":"2016122218201361000_pyw100v2.300","doi-asserted-by":"crossref","unstructured":"Ives-Deliperi VL Howells F Stein DJ Meintjes EM Horn N (2013) The effects of mindfulness-based cognitive therapy in patients with bipolar disorder: A controlled functional MRI investigation. JAffectDisord.","DOI":"10.1016\/j.jad.2013.05.074"},{"key":"2016122218201361000_pyw100v2.301","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.euroneuro.2014.05.013","article-title":"In a double-blind, randomized and placebo-controlled trial, adjuvant allopurinol improved symptoms of mania in in-patients suffering from bipolar disorder","volume":"24","author":"Jahangard","year":"2014","journal-title":"Eur Neuropsychopharmacol"},{"key":"2016122218201361000_pyw100v2.302","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1600-0447.2008.01320.x","article-title":"Neurocognitive functions in euthymic bipolar patients","volume":"119","author":"Jamrozinski","year":"2009","journal-title":"Acta Psychiatr Scand"},{"key":"2016122218201361000_pyw100v2.303","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.155.7.972"},{"key":"2016122218201361000_pyw100v2.304","doi-asserted-by":"crossref","unstructured":"Jauhar S McKenna PJ Laws KR (2016) NICE guidance on psychological treatments for bipolar disorder: searching for the evidence. The lancet Psychiatry.","DOI":"10.1016\/S2215-0366(15)00545-3"},{"key":"2016122218201361000_pyw100v2.305","first-page":"45","article-title":"Preliminary trial of the noradrenergic agonist clonidine in psychiatric patients","volume":"15","author":"Jimerson","year":"1980","journal-title":"Biol Psychiatry"},{"key":"2016122218201361000_pyw100v2.306","first-page":"136","article-title":"Effectiveness of medication in preventing hospitalization of bipolar patients - a register based study of mood stabilizing medication with lithium and anticonvulsants in Sweden","volume":"17","author":"Joas","year":"2015","journal-title":"Bipolar Disord"},{"key":"2016122218201361000_pyw100v2.307","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.3109\/13651509709024748","article-title":"International Psychopharmacology Algorithm Project: Algorithms in psychopharmacology","volume":"1","author":"Jobson","year":"1997","journal-title":"Int J Psychiatry Clin Pract"},{"key":"2016122218201361000_pyw100v2.308","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1080\/15622970802144865","article-title":"Revised Korean medication algorithm for bipolar disorder","volume":"10","author":"Jon","year":"2009","journal-title":"World J Biol Psychiatry"},{"key":"2016122218201361000_pyw100v2.309","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2008.10.012"},{"key":"2016122218201361000_pyw100v2.310","doi-asserted-by":"publisher","DOI":"10.1097\/01.chi.0000129223.89433.74"},{"key":"2016122218201361000_pyw100v2.311","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpsy.2008.12.014"},{"key":"2016122218201361000_pyw100v2.312","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3109\/15622975.2012.669047","article-title":"A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole for the treatment of acute manic or mixed episodes in Asian patients with bipolar I disorder (the AMAZE study)","volume":"15","author":"Kanba","year":"2014","journal-title":"World J Biol Psychiatry"},{"key":"2016122218201361000_pyw100v2.313","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1982.04290090053011"},{"key":"2016122218201361000_pyw100v2.314","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1034\/j.1399-5618.2003.00003.x","article-title":"Right prefrontal TMS versus sham treatment of mania: a controlled study","volume":"5","author":"Kaptsan","year":"2003","journal-title":"Bipolar Disord"},{"key":"2016122218201361000_pyw100v2.315","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1055\/s-0035-1559667","article-title":"Effect of Adjunctive Celecoxib on BDNF in Manic Patients Undergoing Electroconvulsive Therapy: a Randomized Double Blind Controlled Trial","volume":"48","author":"Kargar","year":"2015","journal-title":"Pharmacopsychiatry"},{"key":"2016122218201361000_pyw100v2.316","doi-asserted-by":"publisher","DOI":"10.1007\/BF00426753"},{"key":"2016122218201361000_pyw100v2.317","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(72)92028-4"},{"key":"2016122218201361000_pyw100v2.318","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.jad.2011.10.045","article-title":"Efficacy and safety of olanzapine in the treatment of Japanese patients with bipolar I disorder in a current manic or mixed episode: a randomized, double-blind, placebo- and haloperidol-controlled study","volume":"136","author":"Katagiri","year":"2012","journal-title":"J Affect Disord"},{"key":"2016122218201361000_pyw100v2.319","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/1471-244X-13-138","article-title":"Efficacy and safety of olanzapine for treatment of patients with bipolar depression: Japanese subpopulation analysis of a randomized, double-blind, placebo-controlled study","volume":"13","author":"Katagiri","year":"2013","journal-title":"BMC Psychiatry"},{"key":"2016122218201361000_pyw100v2.320","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2008.05.014"},{"key":"2016122218201361000_pyw100v2.321","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.4.741"},{"key":"2016122218201361000_pyw100v2.322","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.9.1651"},{"key":"2016122218201361000_pyw100v2.323","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v66n0511"},{"key":"2016122218201361000_pyw100v2.324","doi-asserted-by":"crossref","first-page":"626","DOI":"10.4088\/JCP.v67n0414","article-title":"A randomized, double-blind, placebo-controlled 26-week trial of aripiprazole in recently manic patients with bipolar I disorder","volume":"67","author":"Keck","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"2016122218201361000_pyw100v2.325","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v68n1003"},{"key":"2016122218201361000_pyw100v2.326","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2006.03.056"},{"key":"2016122218201361000_pyw100v2.327","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.07m04022"},{"key":"2016122218201361000_pyw100v2.328","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2011.06.005"},{"key":"2016122218201361000_pyw100v2.329","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.12013"},{"key":"2016122218201361000_pyw100v2.330","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jad.2010.10.026","article-title":"Clinical value of early partial symptomatic improvement in the prediction of response and remission during short-term treatment trials in 3369 subjects with bipolar I or II depression","volume":"130","author":"Kemp","year":"2010","journal-title":"J Affect Disord"},{"key":"2016122218201361000_pyw100v2.331","doi-asserted-by":"crossref","first-page":"773","DOI":"10.5694\/j.1326-5377.1975.tb111845.x","article-title":"A controlled study of a tetracyclic antidepressant--maprotiline (Ludiomil)","volume":"1","author":"Kessell","year":"1975","journal-title":"The Medical journal of Australia"},{"key":"2016122218201361000_pyw100v2.332","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291798006862"},{"key":"2016122218201361000_pyw100v2.333","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1471-244X-10-16","article-title":"The study protocol of the Norwegian randomized controlled trial of electroconvulsive therapy in treatment resistant depression in bipolar disorder","volume":"10","author":"Kessler","year":"2010","journal-title":"BMC Psychiatry"},{"key":"2016122218201361000_pyw100v2.334","doi-asserted-by":"crossref","first-page":"e1306","DOI":"10.4088\/JCP.13m08960","article-title":"The effect of electroconvulsive therapy on neurocognitive function in treatment-resistant bipolar disorder depression","volume":"75","author":"Kessler","year":"2014","journal-title":"J Clin Psychiatry"},{"key":"2016122218201361000_pyw100v2.335","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2015.04.012"},{"key":"2016122218201361000_pyw100v2.336","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jpsychires.2009.07.006","article-title":"Rapid antipsychotic response with ziprasidone predicts subsequent acute manic\/mixed episode remission","volume":"44","author":"Ketter","year":"2010","journal-title":"J Psychiatr Res"},{"key":"2016122218201361000_pyw100v2.337","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v67n0113"},{"key":"2016122218201361000_pyw100v2.338","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.57.4.311"},{"key":"2016122218201361000_pyw100v2.339","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145701002322"},{"key":"2016122218201361000_pyw100v2.340","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.4.790"},{"key":"2016122218201361000_pyw100v2.341","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.187.3.229"},{"key":"2016122218201361000_pyw100v2.342","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1600-0447.1994.tb05833.x","article-title":"Psychomotor impairment and cognitive disturbances induced by neuroleptics","volume":"380","author":"King","year":"1994","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"2016122218201361000_pyw100v2.343","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1967.01730190120016"},{"key":"2016122218201361000_pyw100v2.344","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1984.01790130061009"},{"key":"2016122218201361000_pyw100v2.345","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.139.3.255"},{"key":"2016122218201361000_pyw100v2.346","doi-asserted-by":"publisher","DOI":"10.1159\/000054844"},{"key":"2016122218201361000_pyw100v2.347","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291702005251"},{"key":"2016122218201361000_pyw100v2.348","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/00004714-199308000-00007","article-title":"Neuropsychologic effects of lithium discontinuation","volume":"13","author":"Kocsis","year":"1993","journal-title":"J Clin Psychopharmacol"},{"key":"2016122218201361000_pyw100v2.349","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1979.tb06951.x"},{"key":"2016122218201361000_pyw100v2.350","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2005.11.001"},{"key":"2016122218201361000_pyw100v2.351","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2014.02.004"},{"key":"2016122218201361000_pyw100v2.352","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.4088\/JCP.v64n1213","article-title":"Rapid and non-rapid cycling bipolar disorder: a meta-analysis of clinical studies","volume":"64","author":"Kupka","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"2016122218201361000_pyw100v2.353","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2006.00276.x"},{"key":"2016122218201361000_pyw100v2.354","unstructured":"Kusumakar V Yatham L Parikh S (1997) Bipolar disorder: a summary of clinical issues and treatment options. In. Halifax, Nova Scotia: CANMAT Monograph."},{"key":"2016122218201361000_pyw100v2.355","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2011.00975.x"},{"key":"2016122218201361000_pyw100v2.356","first-page":"132","article-title":"Social cognition and interaction training (SCIT) for outpatients with bipolar disorder","volume":"146","author":"Lahera","year":"2013","journal-title":"JAffectDisord"},{"key":"2016122218201361000_pyw100v2.357","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2007.06122018"},{"key":"2016122218201361000_pyw100v2.358","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jad.2015.06.059","article-title":"Asenapine: Efficacy and safety of 5 and 10mg bid in a 3-week, randomized, double-blind, placebo-controlled trial in adults with a manic or mixed episode associated with bipolar I disorder","volume":"190","author":"Landbloom","year":"2016","journal-title":"J Affect Disord"},{"key":"2016122218201361000_pyw100v2.359","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1592\/phco.27.9.1339","article-title":"Agitation associated with aripiprazole initiation","volume":"27","author":"Lea","year":"2007","journal-title":"Pharmacotherapy"},{"key":"2016122218201361000_pyw100v2.360","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpsy.2007.01.1218"},{"key":"2016122218201361000_pyw100v2.361","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2015.01.003"},{"key":"2016122218201361000_pyw100v2.362","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145713000825"},{"key":"2016122218201361000_pyw100v2.363","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/JCP.0000000000000109","article-title":"The effects of add-on low-dose memantine on cytokine levels in bipolar II depression: a 12-week double-blind, randomized controlled trial","volume":"34","author":"Lee","year":"2014","journal-title":"J Clin Psychopharmacol"},{"key":"2016122218201361000_pyw100v2.364","first-page":"47","article-title":"Adjunctive treatment of manic agitation with lorazepam versus haloperidol: a double-blind study","volume":"53","author":"Lenox","year":"1992","journal-title":"J Clin Psychiatry"},{"key":"2016122218201361000_pyw100v2.365","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1176\/ajp.156.2.195","article-title":"Prospective study of fluoxetine treatment and suicidal behavior in affectively ill subjects","volume":"156","author":"Leon","year":"1999","journal-title":"Am J Psychiatry"},{"key":"2016122218201361000_pyw100v2.366","first-page":"89","article-title":"Carbamazepine versus lithium in mania: a double-blind study","volume":"48","author":"Lerer","year":"1987","journal-title":"J Clin Psychiatry"},{"key":"2016122218201361000_pyw100v2.367","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.163.2.232"},{"key":"2016122218201361000_pyw100v2.368","doi-asserted-by":"publisher","DOI":"10.1185\/030079908X253933"},{"key":"2016122218201361000_pyw100v2.369","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1007\/s00213-016-4215-z","article-title":"Efficacy and safety of quetiapine extended release monotherapy in bipolar depression: a multi-center, randomized, double-blind, placebo-controlled trial","volume":"233","author":"Li","year":"2016","journal-title":"Psychopharmacology (Berl)"},{"key":"2016122218201361000_pyw100v2.370","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.164.6.884"},{"key":"2016122218201361000_pyw100v2.371","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2700"},{"key":"2016122218201361000_pyw100v2.372","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.2008.01237.x"},{"key":"2016122218201361000_pyw100v2.373","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0447.108.s419.1.x"},{"key":"2016122218201361000_pyw100v2.374","first-page":"59","article-title":"Enhanced relapse prevention for bipolar disorder by community mental health teams: cluster feasibility randomised trial","volume":"196","author":"Lobban","year":"2010","journal-title":"BrJPsychiatry"},{"key":"2016122218201361000_pyw100v2.375","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2013.13070984"},{"key":"2016122218201361000_pyw100v2.376","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2013.13070985"},{"key":"2016122218201361000_pyw100v2.377","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e31825ccde5"},{"key":"2016122218201361000_pyw100v2.378","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2010.08.017","article-title":"Physical treatments for bipolar disorder: A review of electroconvulsive therapy, stereotactic surgery and other brain stimulation techniques","volume":"132","author":"Loo","year":"2010","journal-title":"J Affect Disord"},{"key":"2016122218201361000_pyw100v2.379","doi-asserted-by":"crossref","unstructured":"Lorenzo-Luaces L Amsterdam JD Soeller I DeRubeis RJ (2016) Rapid versus non-rapid cycling bipolar II depression: response to venlafaxine and lithium and hypomanic risk. Acta Psychiatr Scand.","DOI":"10.1111\/acps.12557"},{"key":"2016122218201361000_pyw100v2.380","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1600-0447.1982.tb00843.x","article-title":"Long-term lithium treatment and psychological functions","volume":"65","author":"Lund","year":"1982","journal-title":"Acta Psychiatr Scand"},{"key":"2016122218201361000_pyw100v2.381","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.159.6.909"},{"key":"2016122218201361000_pyw100v2.382","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.153.2.198"},{"key":"2016122218201361000_pyw100v2.383","doi-asserted-by":"publisher","DOI":"10.4088\/PCC.08m00659"},{"key":"2016122218201361000_pyw100v2.384","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1014662"},{"key":"2016122218201361000_pyw100v2.385","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2009.00761.x"},{"key":"2016122218201361000_pyw100v2.386","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.4088\/JCP.v69n0806","article-title":"A double-blind, randomized, placebo-controlled 4-week study on the efficacy and safety of the purinergic agents allopurinol and dipyridamole adjunctive to lithium in acute bipolar mania","volume":"69","author":"Machado-Vieira","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"2016122218201361000_pyw100v2.387","doi-asserted-by":"crossref","unstructured":"Macritchie K Geddes JR Scott J Haslam D de Lima M Goodwin G (2003) Valproate for acute mood episodes in bipolar disorder. Cochrane Database Syst Rev:CD004052.","DOI":"10.1002\/14651858.CD004052"},{"key":"2016122218201361000_pyw100v2.388","doi-asserted-by":"crossref","unstructured":"Macritchie KA Geddes JR Scott J Haslam DR Goodwin GM (2001) Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder. Cochrane Database Syst Rev:CD003196.","DOI":"10.1002\/14651858.CD003196"},{"key":"2016122218201361000_pyw100v2.389","doi-asserted-by":"publisher","DOI":"10.1590\/S1516-44462011000400011"},{"key":"2016122218201361000_pyw100v2.390","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2010.08.001"},{"key":"2016122218201361000_pyw100v2.391","doi-asserted-by":"publisher","DOI":"10.1177\/0004867413481631"},{"key":"2016122218201361000_pyw100v2.392","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2011.00918.x"},{"key":"2016122218201361000_pyw100v2.393","doi-asserted-by":"publisher","DOI":"10.1177\/0004867415617657"},{"key":"2016122218201361000_pyw100v2.394","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(88)92947-9"},{"key":"2016122218201361000_pyw100v2.395","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2011.00898.x"},{"key":"2016122218201361000_pyw100v2.396","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.141.4.407"},{"key":"2016122218201361000_pyw100v2.397","first-page":"112","article-title":"Functional remediation for bipolar disorder","volume":"7","author":"Martinez-Aran","year":"2011","journal-title":"ClinPractEpidemiolMentHealth"},{"key":"2016122218201361000_pyw100v2.398","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-199710001-00010"},{"key":"2016122218201361000_pyw100v2.399","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/NMD.0000000000000378","article-title":"A Pilot Study of Safety and Efficacy of Cranial Electrotherapy Stimulation in Treatment of Bipolar II Depression","volume":"203","author":"McClure","year":"2015","journal-title":"The Journal of nervous and mental disease"},{"key":"2016122218201361000_pyw100v2.400","first-page":"23","article-title":"Valproate in psychiatric disorders: literature review and clinical guidelines","volume":"50","author":"McElroy","year":"1989","journal-title":"J Clin Psychiatry"},{"key":"2016122218201361000_pyw100v2.401","first-page":"142","article-title":"A randomized comparison of divalproex oral loading versus haloperidol in the initial treatment of acute psychotic mania","volume":"57","author":"McElroy","year":"1996","journal-title":"J Clin Psychiatry"},{"key":"2016122218201361000_pyw100v2.402","doi-asserted-by":"crossref","first-page":"557","DOI":"10.4088\/JCP.08m04854yel","article-title":"Randomized, double-blind, placebo-controlled study of divalproex extended release loading monotherapy in ambulatory bipolar spectrum disorder patients with moderate-to-severe hypomania or mild mania","volume":"71","author":"McElroy","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"2016122218201361000_pyw100v2.403","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0000000000000051"},{"key":"2016122218201361000_pyw100v2.404","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/YIC.0b013e3283400d35","article-title":"A randomized, placebo-controlled study of adjunctive ramelteon in ambulatory bipolar I disorder with manic symptoms and sleep disturbance","volume":"26","author":"McElroy","year":"2010","journal-title":"Int Clin Psychopharmacol"},{"key":"2016122218201361000_pyw100v2.405","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.08m04942gre"},{"key":"2016122218201361000_pyw100v2.406","doi-asserted-by":"crossref","unstructured":"McGirr A Berlim MT Bond DJ Fleck MP Yatham LN Lam RW (2014) A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes. Psychol Med:1\u201312.","DOI":"10.1017\/S0033291714001603"},{"key":"2016122218201361000_pyw100v2.407","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2005.02.006"},{"key":"2016122218201361000_pyw100v2.408","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2013.04.025"},{"key":"2016122218201361000_pyw100v2.409","doi-asserted-by":"crossref","first-page":"398","DOI":"10.4088\/JCP.14m09410","article-title":"Lurasidone in the treatment of bipolar depression with mixed (subsyndromal hypomanic) features: post hoc analysis of a randomized placebo-controlled trial","volume":"76","author":"McIntyre","year":"2015","journal-title":"J Clin Psychiatry"},{"key":"2016122218201361000_pyw100v2.410","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2009.00748.x"},{"key":"2016122218201361000_pyw100v2.411","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2010.04.005"},{"key":"2016122218201361000_pyw100v2.412","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2009.12.028"},{"key":"2016122218201361000_pyw100v2.413","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.12006"},{"key":"2016122218201361000_pyw100v2.414","doi-asserted-by":"publisher","DOI":"10.1517\/14656560903448837"},{"key":"2016122218201361000_pyw100v2.415","first-page":"69","article-title":"The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid metabolic disorders","volume":"24","author":"McIntyre","year":"2012","journal-title":"Ann Clin Psychiatry"},{"key":"2016122218201361000_pyw100v2.416","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2009.01.014"},{"key":"2016122218201361000_pyw100v2.417","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200108000-00006"},{"key":"2016122218201361000_pyw100v2.418","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.116.535.621"},{"key":"2016122218201361000_pyw100v2.419","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.133.4.373"},{"key":"2016122218201361000_pyw100v2.420","first-page":"1429","article-title":"Cognitive behaviour therapy and supportive therapy for bipolar disorders: relapse rates for treatment period and 2-year follow-up","volume":"42","author":"Meyer","year":"2012","journal-title":"PsycholMed"},{"key":"2016122218201361000_pyw100v2.421","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2013.874988"},{"key":"2016122218201361000_pyw100v2.422","first-page":"904","article-title":"A randomized study of family-focused psychoeducation and pharmacotherapy in the outpatient management of bipolar disorder","volume":"60","author":"Miklowitz","year":"2003","journal-title":"ArchGenPsychiatry"},{"key":"2016122218201361000_pyw100v2.423","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(00)00931-8"},{"key":"2016122218201361000_pyw100v2.424","first-page":"419","article-title":"Psychosocial treatments for bipolar depression: a 1-year randomized trial from the Systematic Treatment Enhancement Program","volume":"64","author":"Miklowitz","year":"2007","journal-title":"ArchGenPsychiatry"},{"key":"2016122218201361000_pyw100v2.425","first-page":"1340","article-title":"Intensive psychosocial intervention enhances functioning in patients with bipolar depression: results from a 9-month randomized controlled trial","volume":"164","author":"Miklowitz","year":"2007","journal-title":"AmJPsychiatry"},{"key":"2016122218201361000_pyw100v2.426","doi-asserted-by":"publisher","DOI":"10.1046\/j.1399-5618.2003.00070.x"},{"key":"2016122218201361000_pyw100v2.427","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.157.3.463"},{"key":"2016122218201361000_pyw100v2.428","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12991-015-0057-z","article-title":"Psychosocial treatment and interventions for bipolar disorder: a systematic review","volume":"14","author":"Miziou","year":"2015","journal-title":"Annals of general psychiatry"},{"key":"2016122218201361000_pyw100v2.429","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/HRP.0000000000000018","article-title":"The psychopharmacology algorithm project at the Harvard South Shore Program: an algorithm for acute mania","volume":"22","author":"Mohammad","year":"2014","journal-title":"Harv Rev Psychiatry"},{"key":"2016122218201361000_pyw100v2.430","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2535"},{"key":"2016122218201361000_pyw100v2.431","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-977X(00)00140-1"},{"key":"2016122218201361000_pyw100v2.432","doi-asserted-by":"crossref","first-page":"36424","DOI":"10.5539\/gjhs.v6n6p163","article-title":"Risperidone versus risperidone plus sodium valproate for treatment of bipolar disorders: a randomized, double-blind clinical-trial","volume":"6","author":"Moosavi","year":"2014","journal-title":"Global journal of health science"},{"key":"2016122218201361000_pyw100v2.433","doi-asserted-by":"publisher","DOI":"10.1002\/hup.2369"},{"key":"2016122218201361000_pyw100v2.434","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2007.04.008"},{"key":"2016122218201361000_pyw100v2.435","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200004000-00012"},{"key":"2016122218201361000_pyw100v2.436","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2013.04.032"},{"key":"2016122218201361000_pyw100v2.437","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e318266854c"},{"key":"2016122218201361000_pyw100v2.438","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s11920-015-0603-z","article-title":"Management of adverse effects of mood stabilizers","volume":"17","author":"Murru","year":"2015","journal-title":"Curr Psychiatry Rep"},{"key":"2016122218201361000_pyw100v2.439","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2008.01735.x"},{"key":"2016122218201361000_pyw100v2.440","doi-asserted-by":"crossref","first-page":"813","DOI":"10.4088\/JCP.09m05570gre","article-title":"Acute efficacy of divalproex sodium versus placebo in mood stabilizer-naive bipolar I or II depression: a double-blind, randomized, placebo-controlled trial","volume":"72","author":"Muzina","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"2016122218201361000_pyw100v2.441","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-5618.2003.00011.x"},{"key":"2016122218201361000_pyw100v2.442","unstructured":"National Collaborating Centre for Mental Health (2006) Bipolar disorder.The management of bipolar disorder in adults, children and adolescents, in primary and secondary care. CG38 NICE Guideline."},{"key":"2016122218201361000_pyw100v2.443","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v69n0808"},{"key":"2016122218201361000_pyw100v2.444","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.158.6.906"},{"key":"2016122218201361000_pyw100v2.445","doi-asserted-by":"publisher","DOI":"10.1002\/hup.912"},{"key":"2016122218201361000_pyw100v2.446","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2009.00737.x"},{"key":"2016122218201361000_pyw100v2.447","unstructured":"NHS U (2014) Antidepressants - Side effects In."},{"key":"2016122218201361000_pyw100v2.448","unstructured":"NICE (2014) Bipolar disorder. In."},{"key":"2016122218201361000_pyw100v2.449","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/YIC.0000000000000058","article-title":"Predictors of placebo response in bipolar depression","volume":"30","author":"Nierenberg","year":"2015","journal-title":"Int Clin Psychopharmacol"},{"key":"2016122218201361000_pyw100v2.450","doi-asserted-by":"publisher","DOI":"10.1046\/j.1528-1157.2002.40001.x"},{"key":"2016122218201361000_pyw100v2.451","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2007.04.020"},{"key":"2016122218201361000_pyw100v2.452","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2010.05.018"},{"key":"2016122218201361000_pyw100v2.453","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2011.10.015"},{"key":"2016122218201361000_pyw100v2.454","unstructured":"Nolen W Kupka R Schulte P Knoppert-van der Klein E Honig A Reichart C (2008) Richtlijn bipolaire stoornissen. 2 ed. Utrecht: De Tijdstrom Uitgerverij BV."},{"key":"2016122218201361000_pyw100v2.455","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.12027"},{"key":"2016122218201361000_pyw100v2.456","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2012.06.023"},{"key":"2016122218201361000_pyw100v2.457","first-page":"573","article-title":"Lithium treatment of depression","volume":"35","author":"Noyes","year":"1974","journal-title":"Diseases of the nervous system"},{"key":"2016122218201361000_pyw100v2.458","doi-asserted-by":"publisher","DOI":"10.1016\/0010-440X(74)90015-7"},{"key":"2016122218201361000_pyw100v2.459","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.333.7561.220"},{"key":"2016122218201361000_pyw100v2.460","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-014-0197-8"},{"key":"2016122218201361000_pyw100v2.461","doi-asserted-by":"publisher","DOI":"10.1007\/BF00428308"},{"key":"2016122218201361000_pyw100v2.462","doi-asserted-by":"publisher","DOI":"10.1007\/BF00431111"},{"key":"2016122218201361000_pyw100v2.463","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1014497"},{"key":"2016122218201361000_pyw100v2.464","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/pds.1932","article-title":"Antiepileptic drugs and risk of suicide: a nationwide study","volume":"19","author":"Olesen","year":"2010","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2016122218201361000_pyw100v2.465","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-002-1056-8"},{"key":"2016122218201361000_pyw100v2.466","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2011.11010163"},{"key":"2016122218201361000_pyw100v2.467","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1989.01810100100021"},{"key":"2016122218201361000_pyw100v2.468","doi-asserted-by":"crossref","first-page":"e1186","DOI":"10.4088\/JCP.14com09427","article-title":"When positive isn\u2019t positive: the hopes and disappointments of clinical trials","volume":"75","author":"Ostacher","year":"2014","journal-title":"J Clin Psychiatry"},{"key":"2016122218201361000_pyw100v2.469","doi-asserted-by":"crossref","unstructured":"Ostacher MJ Tandon R Suppes T (2015a) Florida Best Practice Psychotherapeutic Medication Guidelines for Adults With Bipolar Disorder: a novel, practical, patient-centered guide for clinicians. J Clin Psychiatry.","DOI":"10.4088\/JCP.15cs09841"},{"key":"2016122218201361000_pyw100v2.470","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40345-015-0026-0","article-title":"Patterns of response to aripiprazole, lithium, haloperidol, and placebo across factor scores of mania","volume":"3","author":"Ostacher","year":"2015","journal-title":"International journal of bipolar disorders"},{"key":"2016122218201361000_pyw100v2.471","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1600-0447.2008.01201.x","article-title":"Correlates of subjective and objective burden among caregivers of patients with bipolar disorder","volume":"118","author":"Ostacher","year":"2008","journal-title":"Acta PsychiatrScand"},{"key":"2016122218201361000_pyw100v2.472","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2013.13020185"},{"key":"2016122218201361000_pyw100v2.473","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s40261-012-0009-1","article-title":"Achieving and sustaining remission in bipolar I disorder with ziprasidone: a post hoc analysis of a 24-week, double-blind, placebo-controlled study","volume":"32","author":"Pae","year":"2012","journal-title":"Clin Drug Investig"},{"key":"2016122218201361000_pyw100v2.474","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1399-5618.2011.00931.x","article-title":"Visuospatial working memory deficits in remitted patients with bipolar disorder: susceptibility to the effects of GABAergic agonists","volume":"13","author":"Pan","year":"2011","journal-title":"Bipolar Disord"},{"key":"2016122218201361000_pyw100v2.475","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-5618.2000.20305.x"},{"key":"2016122218201361000_pyw100v2.476","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2006.01.024"},{"key":"2016122218201361000_pyw100v2.477","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/JCP.0000000000000323","article-title":"A 13-week, randomized double-blind, placebo-controlled, cross-over trial of ziprasidone in bipolar spectrum disorder","volume":"35","author":"Patkar","year":"2015","journal-title":"J Clin Psychopharmacol"},{"key":"2016122218201361000_pyw100v2.478","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.410"},{"key":"2016122218201361000_pyw100v2.479","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.143.5.652"},{"key":"2016122218201361000_pyw100v2.480","first-page":"338","article-title":"The association between meditation practice and treatment outcome in Mindfulness-based Cognitive Therapy for bipolar disorder","volume":"51","author":"Perich","year":"2013","journal-title":"BehavResTher"},{"key":"2016122218201361000_pyw100v2.481","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/acps.12033","article-title":"A randomized controlled trial of mindfulness-based cognitive therapy for bipolar disorder","volume":"127","author":"Perich","year":"2013","journal-title":"Acta PsychiatrScand"},{"key":"2016122218201361000_pyw100v2.482","doi-asserted-by":"crossref","first-page":"509","DOI":"10.4088\/JCP.v67n0401","article-title":"Atypical antipsychotics in the treatment of mania: a meta-analysis of randomized, placebo-controlled trials","volume":"67","author":"Perlis","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"2016122218201361000_pyw100v2.483","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v67n1112"},{"key":"2016122218201361000_pyw100v2.484","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.64.6.689"},{"key":"2016122218201361000_pyw100v2.485","doi-asserted-by":"publisher","DOI":"10.1159\/000096363"},{"key":"2016122218201361000_pyw100v2.486","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.318.7177.149"},{"key":"2016122218201361000_pyw100v2.487","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1972.tb04389.x"},{"key":"2016122218201361000_pyw100v2.488","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v63n1207"},{"key":"2016122218201361000_pyw100v2.489","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2010.04.025"},{"key":"2016122218201361000_pyw100v2.490","first-page":"490","article-title":"The comparative efficacy and safety of carbamazepine versus lithium: a randomized, double-blind 3-year trial in 83 patients","volume":"47","author":"Placidi","year":"1986","journal-title":"J Clin Psychiatry"},{"key":"2016122218201361000_pyw100v2.491","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.127.3.351"},{"key":"2016122218201361000_pyw100v2.492","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1991.01810250064008"},{"key":"2016122218201361000_pyw100v2.493","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12991-015-0053-3","article-title":"Revisiting loxapine: a systematic review","volume":"14","author":"Popovic","year":"2015","journal-title":"Ann Gen Psychiatry"},{"key":"2016122218201361000_pyw100v2.494","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s00213-010-2056-8","article-title":"Number needed to treat analyses of drugs used for maintenance treatment of bipolar disorder","volume":"213","author":"Popovic","year":"2010","journal-title":"Psychopharmacology (Berl)"},{"key":"2016122218201361000_pyw100v2.495","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.149.12.1727"},{"key":"2016122218201361000_pyw100v2.496","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.143.1.29"},{"key":"2016122218201361000_pyw100v2.497","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1781(87)90064-3"},{"key":"2016122218201361000_pyw100v2.498","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1983.04390010083010"},{"key":"2016122218201361000_pyw100v2.499","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1034\/j.1399-5618.2001.30505.x","article-title":"Rate of switch in bipolar patients prospectively treated with second-generation antidepressants as augmentation to mood stabilizers","volume":"3","author":"Post","year":"2001","journal-title":"Bipolar Disord"},{"key":"2016122218201361000_pyw100v2.500","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1046\/j.1399-5618.2003.00065.x","article-title":"A re-evaluation of the role of antidepressants in the treatment of bipolar depression: data from the Stanley Foundation Bipolar Network","volume":"5","author":"Post","year":"2003","journal-title":"Bipolar Disord"},{"key":"2016122218201361000_pyw100v2.501","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.105.013045"},{"key":"2016122218201361000_pyw100v2.502","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000169068.34322.70"},{"key":"2016122218201361000_pyw100v2.503","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2008.12.020"},{"key":"2016122218201361000_pyw100v2.504","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1972.01750200050011"},{"key":"2016122218201361000_pyw100v2.505","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1973.04200030104017"},{"key":"2016122218201361000_pyw100v2.506","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1973.01750330035006"},{"key":"2016122218201361000_pyw100v2.507","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1983.01790220086014"},{"key":"2016122218201361000_pyw100v2.508","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1111\/j.1532-5415.2012.04207.x","article-title":"Antiepileptic drug monotherapy exposure and suicide-related behavior in older veterans","volume":"60","author":"Pugh","year":"2012","journal-title":"J Am Geriatr Soc"},{"key":"2016122218201361000_pyw100v2.509","doi-asserted-by":"publisher","DOI":"10.1002\/hup.1096"},{"key":"2016122218201361000_pyw100v2.510","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2010.01.015"},{"key":"2016122218201361000_pyw100v2.511","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40345-016-0049-1","article-title":"The direct and indirect effects of lurasidone monotherapy on functional improvement among patients with bipolar depression: results from a randomized placebo-controlled trial","volume":"4","author":"Rajagopalan","year":"2016","journal-title":"International journal of bipolar disorders"},{"key":"2016122218201361000_pyw100v2.512","first-page":"482","article-title":"Family-focused treatment versus individual treatment for bipolar disorder: results of a randomized clinical trial","volume":"71","author":"Rea","year":"2003","journal-title":"JConsult ClinPsychol"},{"key":"2016122218201361000_pyw100v2.513","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2013.12.017"},{"key":"2016122218201361000_pyw100v2.514","first-page":"312","article-title":"Impact of a psychoeducational family intervention on caregivers of stabilized bipolar patients","volume":"73","author":"Reinares","year":"2004","journal-title":"PsychotherPsychosom"},{"key":"2016122218201361000_pyw100v2.515","first-page":"511","article-title":"Impact of caregiver group psychoeducation on the course and outcome of bipolar patients in remission: a randomized controlled trial","volume":"10","author":"Reinares","year":"2008","journal-title":"BipolarDisord"},{"key":"2016122218201361000_pyw100v2.516","doi-asserted-by":"crossref","unstructured":"Rendell JM Gijsman HJ Keck P Goodwin GM Geddes JR (2003) Olanzapine alone or in combination for acute mania. Cochrane Database Syst Rev:CD004040.","DOI":"10.1002\/14651858.CD004040"},{"key":"2016122218201361000_pyw100v2.517","doi-asserted-by":"crossref","unstructured":"Rendell JM Gijsman HJ Bauer MS Goodwin GM Geddes GR (2006) Risperidone alone or in combination for acute mania. Cochrane Database Syst Rev:CD004043.","DOI":"10.1002\/14651858.CD004043.pub2"},{"key":"2016122218201361000_pyw100v2.518","doi-asserted-by":"publisher","DOI":"10.1007\/BF00426919"},{"key":"2016122218201361000_pyw100v2.519","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1016\/j.clinthera.2012.09.002","article-title":"Self-reported sedation profile of quetiapine extended-release and quetiapine immediate-release during 6-day initial dose escalation in bipolar depression: a multicenter, randomized, double-blind, phase IV study","volume":"34","author":"Riesenberg","year":"2012","journal-title":"Clin Ther"},{"key":"2016122218201361000_pyw100v2.520","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2006.04.003"},{"key":"2016122218201361000_pyw100v2.521","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00004850-199609000-00008","article-title":"Antidepressant-induced hypomania in obsessive-compulsive disorder","volume":"11","author":"Rihmer","year":"1996","journal-title":"Int Clin Psychopharmacol"},{"key":"2016122218201361000_pyw100v2.522","unstructured":"Robertson B Grunze H Versavel M Costa R Almeida L Soares-da-Silva P (2010) Results of a double-blind, randomized, dose-titration, placebo controlled multicenter trial (SCO\/BIA-2093\u2013203 study) on safety and efficacy of eslicarbazepine acetate (BIA 2\u2013093) for acute manic episodes associated with biopolar I disorder. Bipolar Disord:46."},{"key":"2016122218201361000_pyw100v2.523","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2015.10.032"},{"key":"2016122218201361000_pyw100v2.524","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1755-5949.2009.00089.x","article-title":"Is anticonvulsant treatment of mania a class effect? Data from randomized clinical trials","volume":"17","author":"Rosa","year":"2009","journal-title":"CNS Neurosci Ther"},{"key":"2016122218201361000_pyw100v2.525","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/bdi.12373","article-title":"Anti-inflammatory agents in the treatment of bipolar depression: a systematic review and meta-analysis","volume":"18","author":"Rosenblat","year":"2016","journal-title":"Bipolar Disord"},{"key":"2016122218201361000_pyw100v2.526","first-page":"56","article-title":"The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid personality disorders","volume":"24","author":"Rosenbluth","year":"2012","journal-title":"Ann Clin Psychiatry"},{"key":"2016122218201361000_pyw100v2.527","first-page":"423","article-title":"Prophylactic efficacy of maprotiline on unipolar depression relapse","volume":"52","author":"Rouillon","year":"1991","journal-title":"J Clin Psychiatry"},{"key":"2016122218201361000_pyw100v2.528","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v67n1105"},{"key":"2016122218201361000_pyw100v2.529","doi-asserted-by":"crossref","first-page":"357","DOI":"10.4088\/JCP.v64n0402","article-title":"Texas Medication Algorithm Project, phase 3 (TMAP-3): rationale and study design","volume":"64","author":"Rush","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"2016122218201361000_pyw100v2.530","doi-asserted-by":"crossref","first-page":"284","DOI":"10.4088\/JCP.v60n0503","article-title":"Medication treatment for the severely and persistently mentally ill: the Texas Medication Algorithm Project","volume":"60","author":"Rush","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"2016122218201361000_pyw100v2.531","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2004.00115.x"},{"key":"2016122218201361000_pyw100v2.532","doi-asserted-by":"publisher","DOI":"10.1177\/0269881106059693"},{"key":"2016122218201361000_pyw100v2.533","unstructured":"Sachs GS Printz DJ Kahn DA Carpenter D Docherty JP (2000) The Expert Consensus Guideline Series: Medication Treatment of Bipolar Disorder 2000. Postgrad Med Spec No:1\u2013104."},{"key":"2016122218201361000_pyw100v2.534","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.159.7.1146"},{"key":"2016122218201361000_pyw100v2.535","first-page":"391","article-title":"A double-blind trial of bupropion versus desipramine for bipolar depression","volume":"55","author":"Sachs","year":"1994","journal-title":"J Clin Psychiatry"},{"key":"2016122218201361000_pyw100v2.536","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.09m05934"},{"key":"2016122218201361000_pyw100v2.537","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.4088\/JCP.11m07388","article-title":"Adjunctive oral ziprasidone in patients with acute mania treated with lithium or divalproex, part 1: results of a randomized, double-blind, placebo-controlled trial","volume":"73","author":"Sachs","year":"2012","journal-title":"J Clin Psychiatry"},{"key":"2016122218201361000_pyw100v2.538","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.4088\/JCP.11m07389","article-title":"Adjunctive oral ziprasidone in patients with acute mania treated with lithium or divalproex, part 2: influence of protocol-specific eligibility criteria on signal detection","volume":"73","author":"Sachs","year":"2012","journal-title":"J Clin Psychiatry"},{"key":"2016122218201361000_pyw100v2.539","unstructured":"Sachs GS Collins MA Altshuler LL Ketter TA Suppes T Rasgon NL Frye MA Wozniak P (2001) Divalproex sodium versus placebo in the treatment of bipolar depression. In: 40th Annual Meeting of the American College of Neuropsychopharmacology. San Juan, Puerto Rico."},{"key":"2016122218201361000_pyw100v2.540","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2014.11.018"},{"key":"2016122218201361000_pyw100v2.541","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa064135"},{"key":"2016122218201361000_pyw100v2.542","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2014.05.015"},{"key":"2016122218201361000_pyw100v2.543","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000152877.08088.87"},{"key":"2016122218201361000_pyw100v2.544","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.62.1.37"},{"key":"2016122218201361000_pyw100v2.545","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.addbeh.2006.05.007","article-title":"Divalproex utility in bipolar disorder with co-occurring cocaine dependence: a pilot study","volume":"32","author":"Salloum","year":"2007","journal-title":"Addictive behaviors"},{"key":"2016122218201361000_pyw100v2.546","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2165\/00023210-200822040-00005","article-title":"Intramuscular aripiprazole: a review of its use in the management of agitation in schizophrenia and bipolar I disorder","volume":"22","author":"Sanford","year":"2008","journal-title":"CNS Drugs"},{"key":"2016122218201361000_pyw100v2.547","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-015-0234-2"},{"key":"2016122218201361000_pyw100v2.548","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(02)00334-8"},{"key":"2016122218201361000_pyw100v2.549","doi-asserted-by":"crossref","first-page":"744","DOI":"10.4088\/JCP.09m05659gre","article-title":"Lvetiracetam in the management of bipolar depression: a randomized, double-blind, placebo-controlled trial","volume":"72","author":"Saricicek","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"2016122218201361000_pyw100v2.550","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.10r06710"},{"key":"2016122218201361000_pyw100v2.551","first-page":"459","article-title":"When to start aripiprazole therapy in patients with bipolar mania","volume":"10","author":"Sayyaparaju","year":"2014","journal-title":"Neuropsychiatric disease and treatment"},{"key":"2016122218201361000_pyw100v2.552","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2006.05.023"},{"key":"2016122218201361000_pyw100v2.553","first-page":"6","article-title":"The CANMAT task force recommendations for the management of patients with mood disorders and comorbid anxiety disorders","volume":"24","author":"Schaffer","year":"2012","journal-title":"Ann Clin Psychiatry"},{"key":"2016122218201361000_pyw100v2.554","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.64.4.442"},{"key":"2016122218201361000_pyw100v2.555","doi-asserted-by":"crossref","unstructured":"Schneck CD Miklowitz DJ Miyahara S Araga M Wisniewski S Gyulai L Allen MH Thase ME Sachs GS (2008) The Prospective Course of Rapid-Cycling Bipolar Disorder: Findings From the STEP-BD. Am J Psychiatry.","DOI":"10.1176\/appi.ajp.2007.05081484"},{"key":"2016122218201361000_pyw100v2.556","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2014.13111517"},{"key":"2016122218201361000_pyw100v2.557","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2013.09.010"},{"key":"2016122218201361000_pyw100v2.558","first-page":"313","article-title":"Cognitive-behavioural therapy for severe and recurrent bipolar disorders: randomised controlled trial","volume":"188","author":"Scott","year":"2006","journal-title":"BrJPsychiatry"},{"key":"2016122218201361000_pyw100v2.559","first-page":"176","article-title":"Risperidone compared with both lithium and haloperidol in mania: a double-blind randomized controlled trial","volume":"21","author":"Segal","year":"1998","journal-title":"Clin Neuropharmacol"},{"key":"2016122218201361000_pyw100v2.560","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1399-5618.2007.00481.x","article-title":"Impaired verbal memory and otherwise spared cognition in remitted bipolar patients on monotherapy with lithium or valproate","volume":"9","author":"Senturk","year":"2007","journal-title":"Bipolar Disord"},{"key":"2016122218201361000_pyw100v2.561","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/WNF.0b013e3182055c07","article-title":"Safety and tolerability of lamotrigine: results from 12 placebo-controlled clinical trials and clinical implications","volume":"34","author":"Seo","year":"2010","journal-title":"Clin Neuropharmacol"},{"key":"2016122218201361000_pyw100v2.562","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/WNF.0000000000000011","article-title":"Bupropion as an add-on therapy in depressed bipolar disorder type I patients with comorbid cocaine dependence","volume":"37","author":"Sepede","year":"2014","journal-title":"Clin Neuropharmacol"},{"key":"2016122218201361000_pyw100v2.563","doi-asserted-by":"publisher","DOI":"10.1186\/s40345-014-0015-8"},{"key":"2016122218201361000_pyw100v2.564","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2009.08.013"},{"key":"2016122218201361000_pyw100v2.565","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.143.9.1166"},{"key":"2016122218201361000_pyw100v2.566","doi-asserted-by":"publisher","DOI":"10.1037\/0021-843X.96.1.64"},{"key":"2016122218201361000_pyw100v2.567","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2012.07.016"},{"key":"2016122218201361000_pyw100v2.568","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2008.10.005"},{"key":"2016122218201361000_pyw100v2.569","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v65n1218"},{"key":"2016122218201361000_pyw100v2.570","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.2009.01024.x"},{"key":"2016122218201361000_pyw100v2.571","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1111\/acer.12445","article-title":"A randomized, double-blind, placebo-controlled trial of quetiapine in patients with bipolar disorder, mixed or depressed phase, and alcohol dependence","volume":"38","author":"Sherwood Brown","year":"2014","journal-title":"Alcohol Clin Exp Res"},{"key":"2016122218201361000_pyw100v2.572","doi-asserted-by":"publisher","DOI":"10.1185\/030079904125004493"},{"key":"2016122218201361000_pyw100v2.573","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(04)90013-6"},{"key":"2016122218201361000_pyw100v2.574","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1176\/ajp.147.8.1090","article-title":"Mania in a panic disorder patient treated with fluoxetine","volume":"147","author":"Sholomskas","year":"1990","journal-title":"Am J Psychiatry"},{"key":"2016122218201361000_pyw100v2.575","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1975.01760190036004"},{"key":"2016122218201361000_pyw100v2.576","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/HRP.0000000000000039","article-title":"Is antiepileptic-induced suicidality a data-based class effect or an exaggeration? A comment on the literature","volume":"22","author":"Siamouli","year":"2014","journal-title":"Harv Rev Psychiatry"},{"key":"2016122218201361000_pyw100v2.577","doi-asserted-by":"crossref","first-page":"156","DOI":"10.4088\/JCP.09r05385gre","article-title":"Antidepressants for the acute treatment of bipolar depression: a systematic review and meta-analysis","volume":"72","author":"Sidor","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"2016122218201361000_pyw100v2.578","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-012-0323-6"},{"key":"2016122218201361000_pyw100v2.579","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/bdi.12026","article-title":"Evidence-based treatment strategies for treatment-resistant bipolar depression: a systematic review","volume":"15","author":"Sienaert","year":"2013","journal-title":"Bipolar Disord"},{"key":"2016122218201361000_pyw100v2.580","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.164.6.806"},{"key":"2016122218201361000_pyw100v2.581","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jad.2012.11.001","article-title":"Olanzapine plus fluoxetine for bipolar disorder: a systematic review and meta-analysis","volume":"146","author":"Silva","year":"2013","journal-title":"J Affect Disord"},{"key":"2016122218201361000_pyw100v2.582","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0447.2001.00240.x"},{"key":"2016122218201361000_pyw100v2.583","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0327(93)90057-Q"},{"key":"2016122218201361000_pyw100v2.584","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.163.1.41"},{"key":"2016122218201361000_pyw100v2.585","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.127.11.1555"},{"key":"2016122218201361000_pyw100v2.586","first-page":"265","article-title":"Lithium combined with carbamazepine or haloperidol in the treatment of mania","volume":"31","author":"Small","year":"1995","journal-title":"Psychopharmacol Bull"},{"key":"2016122218201361000_pyw100v2.587","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1991.01810340047006"},{"key":"2016122218201361000_pyw100v2.588","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.2006.00912.x"},{"key":"2016122218201361000_pyw100v2.589","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2009.10.033"},{"key":"2016122218201361000_pyw100v2.590","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2004.06.003"},{"key":"2016122218201361000_pyw100v2.591","doi-asserted-by":"crossref","unstructured":"Sole B Bonnin CM Mayoral M Amann BL Torres I Gonzalez-Pinto A Jimenez E Crespo JM Colom F Tabares-Seisdedos R Reinares M Ayuso-Mateos JL Soria S Garcia-Portilla MP Ibanez A Vieta E Martinez-Aran A Torrent C , the CFRG (2014) Functional remediation for patients with bipolar II disorder: Improvement of functioning and subsyndromal symptoms. Eur Neuropsychopharmacol.","DOI":"10.1016\/S0924-977X(14)70697-2"},{"key":"2016122218201361000_pyw100v2.592","first-page":"94","article-title":"Suicide risk in bipolar disorder during treatment with lithium and valproate","volume":"17","author":"Song","year":"2015","journal-title":"Bipolar Disord"},{"key":"2016122218201361000_pyw100v2.593","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1176\/ajp.137.9.1042","article-title":"Effects of lithium carbonate on memory and other cognitive functions","volume":"137","author":"Squire","year":"1980","journal-title":"Am J Psychiatry"},{"key":"2016122218201361000_pyw100v2.594","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1177\/070674379504000906","article-title":"Treatment of acute bipolar depression: a review of the literature","volume":"40","author":"Srisurapanont","year":"1995","journal-title":"Canadian journal of psychiatry"},{"key":"2016122218201361000_pyw100v2.595","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2009.06.023"},{"key":"2016122218201361000_pyw100v2.596","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1176\/ajp.148.10.1403b","article-title":"Fluoxetine-induced mania in a patient with obsessive-compulsive disorder","volume":"148","author":"Steiner","year":"1991","journal-title":"Am J Psychiatry"},{"key":"2016122218201361000_pyw100v2.597","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(71)91886-1"},{"key":"2016122218201361000_pyw100v2.598","first-page":"356","article-title":"Lithium-associated cognitive and functional deficits reduced by a switch to divalproex sodium: a case series","volume":"57","author":"Stoll","year":"1996","journal-title":"J Clin Psychiatry"},{"key":"2016122218201361000_pyw100v2.599","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.56.5.407"},{"key":"2016122218201361000_pyw100v2.600","doi-asserted-by":"crossref","unstructured":"Stoll K Goncalves N Krober H Demisch K Bellaire W (1989) Use of Carbamazepine in affective illness. In: New directions in affective disorders ( Lerer G Gershon S , eds), pp 540\u2013544. New York: Springer-Verlag.","DOI":"10.1007\/978-1-4612-3524-8_115"},{"key":"2016122218201361000_pyw100v2.601","unstructured":"Suppes T Calabrese J Silva R (2013) Lurasidone adjunctive therapy with lithium or valproate for the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study (PREVAIL 3). Neuropsychopharmacology 38:abstract no. W147."},{"key":"2016122218201361000_pyw100v2.602","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2005.07.011"},{"key":"2016122218201361000_pyw100v2.603","doi-asserted-by":"publisher","DOI":"10.1080\/15622970701317265"},{"key":"2016122218201361000_pyw100v2.604","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2007.08.015"},{"key":"2016122218201361000_pyw100v2.605","first-page":"469","article-title":"Algorithms for the treatment of bipolar manic-depressive illness","volume":"31","author":"Suppes","year":"1995","journal-title":"Psychopharmacol Bull"},{"key":"2016122218201361000_pyw100v2.606","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2008.08020189"},{"key":"2016122218201361000_pyw100v2.607","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2009.10.007"},{"key":"2016122218201361000_pyw100v2.608","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.12m08297"},{"key":"2016122218201361000_pyw100v2.609","doi-asserted-by":"crossref","unstructured":"Suppes T Silva R Cucchiaro J Mao Y Targum S Streicher C Pikalov A Loebel A (2015) Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features: A Randomized, Double-Blind, Placebo-Controlled Study. Am J Psychiatry:appiajp201515060770.","DOI":"10.1176\/appi.ajp.2015.15060770"},{"key":"2016122218201361000_pyw100v2.610","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v62n0607"},{"key":"2016122218201361000_pyw100v2.611","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v63n0404"},{"key":"2016122218201361000_pyw100v2.612","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v64n0403"},{"key":"2016122218201361000_pyw100v2.613","doi-asserted-by":"crossref","first-page":"827","DOI":"10.2147\/DDDT.S63779","article-title":"Quetiapine for acute bipolar depression: a systematic review and meta-analysis","volume":"8","author":"Suttajit","year":"2014","journal-title":"Drug design, development and therapy"},{"key":"2016122218201361000_pyw100v2.614","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1997.01830130041008"},{"key":"2016122218201361000_pyw100v2.615","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.09r05192gre"},{"key":"2016122218201361000_pyw100v2.616","first-page":"211","article-title":"A randomized pilot study of psychotherapy and quetiapine for the acute treatment of bipolar II depression","volume":"14","author":"Swartz","year":"2012","journal-title":"BipolarDisord"},{"key":"2016122218201361000_pyw100v2.617","doi-asserted-by":"publisher","DOI":"10.1159\/000341309"},{"key":"2016122218201361000_pyw100v2.618","first-page":"94","article-title":"A randomized, placebo-controlled proof-of-concept trial of adjunctive topiramate for alcohol use disorders in bipolar disorder","volume":"25","author":"Sylvia","year":"2016","journal-title":"The American journal on addictions \/ American Academy of Psychiatrists in Alcoholism and Addictions"},{"key":"2016122218201361000_pyw100v2.619","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-11-101"},{"key":"2016122218201361000_pyw100v2.620","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e31823f872f"},{"key":"2016122218201361000_pyw100v2.621","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jpsychires.2015.06.015","article-title":"Antidepressant dose and treatment response in bipolar depression: reanalysis of the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) data","volume":"68","author":"Tada","year":"2015","journal-title":"J Psychiatr Res"},{"key":"2016122218201361000_pyw100v2.622","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145709991039"},{"key":"2016122218201361000_pyw100v2.623","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e3181ad223f"},{"key":"2016122218201361000_pyw100v2.624","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jad.2010.11.009","article-title":"Comparative efficacy and acceptability of mood stabilizer and second generation antipsychotic monotherapy for acute mania--a systematic review and meta-analysis","volume":"134","author":"Tarr","year":"2010","journal-title":"J Affect Disord"},{"key":"2016122218201361000_pyw100v2.625","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2011.00904.x"},{"key":"2016122218201361000_pyw100v2.626","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.149.2.195"},{"key":"2016122218201361000_pyw100v2.627","doi-asserted-by":"publisher","DOI":"10.3109\/13651501.2011.632680"},{"key":"2016122218201361000_pyw100v2.628","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000248603.76231.b7"},{"key":"2016122218201361000_pyw100v2.629","doi-asserted-by":"publisher","DOI":"10.1097\/jcp.0b013e3181618eb4"},{"key":"2016122218201361000_pyw100v2.630","doi-asserted-by":"crossref","first-page":"681","DOI":"10.2174\/1570159X13666150115220221","article-title":"The incidence of akathisia in the treatment of schizophrenia with aripiprazole, asenapine and lurasidone: a meta-analysis","volume":"13","author":"Thomas","year":"2015","journal-title":"Curr Neuropharmacol"},{"key":"2016122218201361000_pyw100v2.631","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2013.01.022"},{"key":"2016122218201361000_pyw100v2.632","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.152.3.413"},{"key":"2016122218201361000_pyw100v2.633","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2008.11.003"},{"key":"2016122218201361000_pyw100v2.634","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2014.04.003"},{"key":"2016122218201361000_pyw100v2.635","first-page":"496","article-title":"Thrombocytopenia associated with carbamazepine: a case series","volume":"52","author":"Tohen","year":"1991","journal-title":"J Clin Psychiatry"},{"key":"2016122218201361000_pyw100v2.636","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.112.108357"},{"key":"2016122218201361000_pyw100v2.637","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.163.2.247"},{"key":"2016122218201361000_pyw100v2.638","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.159.6.1011"},{"key":"2016122218201361000_pyw100v2.639","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.7.1263"},{"key":"2016122218201361000_pyw100v2.640","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.107.041301"},{"key":"2016122218201361000_pyw100v2.641","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.57.9.841"},{"key":"2016122218201361000_pyw100v2.642","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.184.4.337"},{"key":"2016122218201361000_pyw100v2.643","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1176\/ajp.156.5.702","article-title":"Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group","volume":"156","author":"Tohen","year":"1999","journal-title":"Am J Psychiatry"},{"key":"2016122218201361000_pyw100v2.644","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.59.1.62"},{"key":"2016122218201361000_pyw100v2.645","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.60.12.1218"},{"key":"2016122218201361000_pyw100v2.646","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.60.11.1079"},{"key":"2016122218201361000_pyw100v2.647","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v69n1113"},{"key":"2016122218201361000_pyw100v2.648","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.162.7.1281"},{"key":"2016122218201361000_pyw100v2.649","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2011.00973.x"},{"key":"2016122218201361000_pyw100v2.650","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0447.2001.00464.x"},{"key":"2016122218201361000_pyw100v2.651","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1034\/j.1600-0447.2003.00126.x","article-title":"Rapid-cycling bipolar disorder: effects of long-term treatments","volume":"108","author":"Tondo","year":"2003","journal-title":"Acta Psychiatr Scand"},{"key":"2016122218201361000_pyw100v2.652","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1600-0447.2009.01514.x","article-title":"Mania associated with antidepressant treatment: comprehensive meta-analytic review","volume":"121","author":"Tondo","year":"2010","journal-title":"Acta Psychiatr Scand"},{"key":"2016122218201361000_pyw100v2.653","first-page":"852","article-title":"Efficacy of functional remediation in bipolar disorder: a multicenter randomized controlled study","volume":"170","author":"Torrent","year":"2013","journal-title":"AmJPsychiatry"},{"key":"2016122218201361000_pyw100v2.654","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.4088\/JCP.v68n1002","article-title":"Self-reported history of manic\/hypomanic switch associated with antidepressant use: data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)","volume":"68","author":"Truman","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"2016122218201361000_pyw100v2.655","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000434"},{"key":"2016122218201361000_pyw100v2.656","doi-asserted-by":"publisher","DOI":"10.1186\/s12991-015-0081-z"},{"key":"2016122218201361000_pyw100v2.657","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.2009.01537.x"},{"key":"2016122218201361000_pyw100v2.658","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2011.00887.x"},{"key":"2016122218201361000_pyw100v2.659","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.08m04152"},{"key":"2016122218201361000_pyw100v2.660","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.108.057612"},{"key":"2016122218201361000_pyw100v2.661","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-8-4"},{"key":"2016122218201361000_pyw100v2.662","doi-asserted-by":"crossref","unstructured":"Vasudev A Macritchie K Watson S Geddes JR Young AH (2008) Oxcarbazepine in the maintenance treatment of bipolar disorder. Cochrane Database Syst Rev:CD005171.","DOI":"10.1002\/14651858.CD005171.pub2"},{"key":"2016122218201361000_pyw100v2.663","first-page":"CD004857","article-title":"Oxcarbazepine for acute affective episodes in bipolar disorder","volume":"12","author":"Vasudev","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"2016122218201361000_pyw100v2.664","doi-asserted-by":"publisher","DOI":"10.1007\/s002130000380"},{"key":"2016122218201361000_pyw100v2.665","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145713000023"},{"key":"2016122218201361000_pyw100v2.666","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jad.2015.05.016","article-title":"Efficacy and tolerability of treatments for bipolar depression","volume":"183","author":"Vazquez","year":"2015","journal-title":"J Affect Disord"},{"key":"2016122218201361000_pyw100v2.667","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.euroneuro.2015.07.013","article-title":"Recurrence rates in bipolar disorder: Systematic comparison of long-term prospective, naturalistic studies versus randomized controlled trials","volume":"25","author":"Vazquez","year":"2015","journal-title":"Eur Neuropsychopharmacol"},{"key":"2016122218201361000_pyw100v2.668","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jad.2016.03.034","article-title":"Acetylcholinesterase inhibitors and memantine in bipolar disorder: A systematic review and best evidence synthesis of the efficacy and safety for multiple disease dimensions","volume":"197","author":"Veronese","year":"2016","journal-title":"J Affect Disord"},{"key":"2016122218201361000_pyw100v2.669","first-page":"27","article-title":"Psychiatry: from interest in conflicts to conflicts of interest","volume":"6","author":"Vieta","year":"2007","journal-title":"World psychiatry: official journal of the World Psychiatric Association"},{"key":"2016122218201361000_pyw100v2.670","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2014.14070826"},{"key":"2016122218201361000_pyw100v2.671","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.rpsm.2015.03.003","article-title":"[Personalised medicine applied to mental health: Precision psychiatry]","volume":"8","author":"Vieta","year":"2015","journal-title":"Revista de psiquiatria y salud mental"},{"key":"2016122218201361000_pyw100v2.672","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1176\/ajp.149.9.1282-a","article-title":"Antidepressant-induced mania in obsessive-compulsive disorder","volume":"149","author":"Vieta","year":"1992","journal-title":"Am J Psychiatry"},{"key":"2016122218201361000_pyw100v2.673","doi-asserted-by":"publisher","DOI":"10.1185\/030079905X46340"},{"key":"2016122218201361000_pyw100v2.674","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2007.00479.x"},{"key":"2016122218201361000_pyw100v2.675","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2008.06.001"},{"key":"2016122218201361000_pyw100v2.676","doi-asserted-by":"publisher","DOI":"10.1177\/0269881108099418"},{"key":"2016122218201361000_pyw100v2.677","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v63n0607"},{"key":"2016122218201361000_pyw100v2.678","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2010.00815.x"},{"key":"2016122218201361000_pyw100v2.679","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2012.03.004"},{"key":"2016122218201361000_pyw100v2.680","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v67n0320"},{"key":"2016122218201361000_pyw100v2.681","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2008.07101560"},{"key":"2016122218201361000_pyw100v2.682","first-page":"579","article-title":"Treatment options for bipolar depression: a systematic review of randomized, controlled trials","volume":"30","author":"Vieta","year":"2010","journal-title":"`"},{"key":"2016122218201361000_pyw100v2.683","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145711000885"},{"key":"2016122218201361000_pyw100v2.684","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.4088\/JCP.v65n1019","article-title":"Comparison of rapid-cycling and non-rapid-cycling bipolar I manic patients during treatment with olanzapine: analysis of pooled data","volume":"65","author":"Vieta","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"2016122218201361000_pyw100v2.685","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.187.3.235"},{"key":"2016122218201361000_pyw100v2.686","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145708008596"},{"key":"2016122218201361000_pyw100v2.687","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2014.13111501"},{"key":"2016122218201361000_pyw100v2.688","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-014-3453-1"},{"key":"2016122218201361000_pyw100v2.689","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.150.2.180"},{"key":"2016122218201361000_pyw100v2.690","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2012.05.029"},{"key":"2016122218201361000_pyw100v2.691","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.145.2.179"},{"key":"2016122218201361000_pyw100v2.692","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/bdi.12202","article-title":"Allopurinol for mania: a randomized trial of allopurinol versus placebo as add-on treatment to mood stabilizers and\/or antipsychotic agents in manic patients with bipolar disorder","volume":"16","author":"Weiser","year":"2014","journal-title":"Bipolar Disord"},{"key":"2016122218201361000_pyw100v2.693","unstructured":"Weisler R Dunn J English P (2003) Adjunctive Ziprasidone for acute bipolar mania: randomized, placebo-controlled trial. In: 4th International Forum on Mood and Anxiety Disorders. Monte Carlo, Monaco."},{"key":"2016122218201361000_pyw100v2.694","doi-asserted-by":"crossref","first-page":"478","DOI":"10.4088\/JCP.v65n0405","article-title":"A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes","volume":"65","author":"Weisler","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"2016122218201361000_pyw100v2.695","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.11m06878"},{"key":"2016122218201361000_pyw100v2.696","doi-asserted-by":"crossref","first-page":"323","DOI":"10.4088\/JCP.v66n0308","article-title":"Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: a multicenter, randomized, double-blind, placebo-controlled trial","volume":"66","author":"Weisler","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"2016122218201361000_pyw100v2.697","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v69n0510"},{"key":"2016122218201361000_pyw100v2.698","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200620030-00004"},{"key":"2016122218201361000_pyw100v2.699","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/JCP.0000000000000435","article-title":"Does Insight Affect the Efficacy of Antipsychotics in Acute Mania?: An Individual Patient Data Regression Meta-Analysis","volume":"36","author":"Welten","year":"2016","journal-title":"J Clin Psychopharmacol"},{"key":"2016122218201361000_pyw100v2.700","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.yebeh.2010.08.030","article-title":"Is antiepileptic drug use related to depression and suicidal ideation among patients with epilepsy?","volume":"19","author":"Wen","year":"2011","journal-title":"Epilepsy Behav"},{"key":"2016122218201361000_pyw100v2.701","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0010-440X(86)90042-8","article-title":"Serotonin-uptake inhibitors in obsessive-compulsive disorder: a case report","volume":"27","author":"White","year":"1986","journal-title":"Compr Psychiatry"},{"key":"2016122218201361000_pyw100v2.702","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16043-1"},{"key":"2016122218201361000_pyw100v2.703","first-page":"275","article-title":"Mindfulness-based Cognitive Therapy (MBCT) in bipolar disorder: preliminary evaluation of immediate effects on between-episode functioning","volume":"107","author":"Williams","year":"2008","journal-title":"JAffectDisord"},{"key":"2016122218201361000_pyw100v2.704","doi-asserted-by":"publisher","DOI":"10.1002\/hup.1240"},{"key":"2016122218201361000_pyw100v2.705","first-page":"493","article-title":"Korean Medication Algorithm Project for Bipolar Disorder: third revision","volume":"11","author":"Woo","year":"2015","journal-title":"Neuropsychiatric disease and treatment"},{"key":"2016122218201361000_pyw100v2.706","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2009.02.018"},{"key":"2016122218201361000_pyw100v2.707","doi-asserted-by":"crossref","first-page":"858251","DOI":"10.1155\/2015\/858251","article-title":"Lithium and Valproate Levels Do Not Correlate with Ketamine\u2019s Antidepressant Efficacy in Treatment-Resistant Bipolar Depression","volume":"2015","author":"Xu","year":"2015","journal-title":"Neural plasticity"},{"key":"2016122218201361000_pyw100v2.708","first-page":"1265","article-title":"Olanzapine-valproate combination versus olanzapine or valproate monotherapy in the treatment of bipolar I mania: a randomized controlled study in a Chinese population group","volume":"11","author":"Xu","year":"2015","journal-title":"Neuropsychiatric disease and treatment"},{"key":"2016122218201361000_pyw100v2.709","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000144887.66319.2f"},{"key":"2016122218201361000_pyw100v2.710","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.182.2.141"},{"key":"2016122218201361000_pyw100v2.711","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0b013e328080ca57"},{"key":"2016122218201361000_pyw100v2.712","first-page":"87S","article-title":"Bipolar depression: treatment options","volume":"42","author":"Yatham","year":"1997","journal-title":"Can J Psychiatry"},{"key":"2016122218201361000_pyw100v2.713","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2012.11.042"},{"key":"2016122218201361000_pyw100v2.714","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.114.147587"},{"key":"2016122218201361000_pyw100v2.715","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2006.00432.x"},{"key":"2016122218201361000_pyw100v2.716","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/bdi.12038","article-title":"The evolution of CANMAT Bipolar Disorder Guidelines: past, present, and future","volume":"15","author":"Yatham","year":"2013","journal-title":"Bipolar Disord"},{"key":"2016122218201361000_pyw100v2.717","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2009.00672.x"},{"key":"2016122218201361000_pyw100v2.718","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1399-5618.2005.00219.x","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies","volume":"7","author":"Yatham","year":"2005","journal-title":"Bipolar Disord"},{"key":"2016122218201361000_pyw100v2.719","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.12025"},{"key":"2016122218201361000_pyw100v2.720","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/mp.2015.158","article-title":"Optimal duration of risperidone or olanzapine adjunctive therapy to mood stabilizer following remission of a manic episode: a CANMAT randomized double-blind trial","volume":"21","author":"Yatham","year":"2016","journal-title":"Molecular Psychiatry"},{"key":"2016122218201361000_pyw100v2.721","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.2004.00437.x"},{"key":"2016122218201361000_pyw100v2.722","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/npp.2010.192","article-title":"Efficacy of antimanic treatments: meta-analysis of randomized, controlled trials","volume":"36","author":"Yildiz","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"2016122218201361000_pyw100v2.723","doi-asserted-by":"publisher","DOI":"10.1001\/archgenpsychiatry.2007.43"},{"key":"2016122218201361000_pyw100v2.724","doi-asserted-by":"crossref","unstructured":"Yildiz A Nikodem M Vieta E Correll CU Baldessarini RJ (2014) A network meta-analysis on comparative efficacy and all-cause discontinuation of antimanic treatments in acute bipolar mania. Psychol Med:1\u201319.","DOI":"10.1017\/S0033291714001305"},{"key":"2016122218201361000_pyw100v2.725","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291714001305"},{"key":"2016122218201361000_pyw100v2.726","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3109\/15622975.2012.665177","article-title":"A randomised, placebo-controlled 52-week trial of continued quetiapine treatment in recently depressed patients with bipolar I and bipolar II disorder","volume":"15","author":"Young","year":"2014","journal-title":"World J Biol Psychiatry"},{"key":"2016122218201361000_pyw100v2.727","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.108.049965"},{"key":"2016122218201361000_pyw100v2.728","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.08m04995gre"},{"key":"2016122218201361000_pyw100v2.729","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.157.8.1351"},{"key":"2016122218201361000_pyw100v2.730","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.4088\/JCP.v63n1210","article-title":"A comparison of the efficacy, safety, and tolerability of divalproex sodium and olanzapine in the treatment of bipolar disorder","volume":"63","author":"Zajecka","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"2016122218201361000_pyw100v2.731","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.161.1.169"},{"key":"2016122218201361000_pyw100v2.732","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2007.00530.x"},{"key":"2016122218201361000_pyw100v2.733","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2004.03.013"},{"key":"2016122218201361000_pyw100v2.734","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2011.12.010"},{"key":"2016122218201361000_pyw100v2.735","doi-asserted-by":"publisher","DOI":"10.1177\/070674370805300709"},{"key":"2016122218201361000_pyw100v2.736","doi-asserted-by":"publisher","DOI":"10.1002\/da.22340"},{"key":"2016122218201361000_pyw100v2.737","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2005.06.002"},{"key":"2016122218201361000_pyw100v2.738","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1185\/030079905X38259","article-title":"Service utilization and costs of olanzapine versus divalproex treatment for acute mania: results from a randomized, 47-week clinical trial","volume":"21","author":"Zhu","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"2016122218201361000_pyw100v2.739","doi-asserted-by":"publisher","DOI":"10.1097\/NRL.0b013e3181f79f37"},{"key":"2016122218201361000_pyw100v2.740","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-1781(01)00242-6"}],"container-title":["International Journal of Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ijnp\/article-pdf\/20\/2\/121\/18132267\/pyw100.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T20:03:43Z","timestamp":1749672223000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ijnp\/article-lookup\/doi\/10.1093\/ijnp\/pyw100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,5]]},"references-count":740,"alternative-id":["10.1093\/ijnp\/pyw100"],"URL":"https:\/\/doi.org\/10.1093\/ijnp\/pyw100","relation":{},"ISSN":["1461-1457","1469-5111"],"issn-type":[{"value":"1461-1457","type":"print"},{"value":"1469-5111","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,5]]}}}